<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Selenium supplementation for Hashimoto's thyroiditis - van Zuuren, EJ - 2013 | Cochrane Library</title> <meta content="Selenium supplementation for Hashimoto's thyroiditis - van Zuuren, EJ - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010223.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Selenium supplementation for Hashimoto's thyroiditis - van Zuuren, EJ - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010223.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010223.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Selenium supplementation for Hashimoto's thyroiditis" name="citation_title"/> <meta content="Esther J van Zuuren" name="citation_author"/> <meta content="Leiden University Medical Center" name="citation_author_institution"/> <meta content="E.J.van_Zuuren@lumc.nl" name="citation_author_email"/> <meta content="Amira Y Albusta" name="citation_author"/> <meta content="AMA International University of Bahrain" name="citation_author_institution"/> <meta content="Zbys Fedorowicz" name="citation_author"/> <meta content="The Cochrane Collaboration" name="citation_author_institution"/> <meta content="Ben Carter" name="citation_author"/> <meta content="Cardiff University School of Medicine" name="citation_author_institution"/> <meta content="Hanno Pijl" name="citation_author"/> <meta content="Leiden University Medical Centre" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD010223.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/06/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010223.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010223.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010223.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Dietary Supplements; Hashimoto Disease [*therapy]; Randomized Controlled Trials as Topic; Selenomethionine [*administration &amp; dosage]; Sodium Selenite [*administration &amp; dosage]; Thyroxine [administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010223.pub2&amp;doi=10.1002/14651858.CD010223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="p32VIvbS";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010223\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010223\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","ko","ms","ja","hr","pl","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010223.pub2",title:"Selenium supplementation for Hashimoto\u0027s thyroiditis",firstPublishedDate:"Jun 6, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Metabolic and Endocrine Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=p32VIvbS&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010223.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010223.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010223.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010223.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010223.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010223.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010223.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010223.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010223.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010223.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>12091 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010223.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-sec-0150"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-sec-0044"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-sec-0045"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-sec-0077"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-sec-0139"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/appendices#CD010223-sec-0155"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/table_n/CD010223StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/table_n/CD010223StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Selenium supplementation for Hashimoto's thyroiditis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/information#CD010223-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Esther J van Zuuren</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/information#CD010223-cr-0003">Amira Y Albusta</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/information#CD010223-cr-0004">Zbys Fedorowicz</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/information#CD010223-cr-0005">Ben Carter</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010223.pub2/information#CD010223-cr-0006">Hanno Pijl</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/information/en#CD010223-sec-0168">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 June 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010223.pub2">https://doi.org/10.1002/14651858.CD010223.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010223-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010223-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010223-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010223-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD010223-abs-0004">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010223-abs-0003">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010223-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010223-abs-0001" lang="en"> <section id="CD010223-sec-0001"> <h3 class="title" id="CD010223-sec-0001">Background</h3> <p>Hashimoto's thyroiditis is a common auto‐immune disorder. The most common presenting symptoms may include anxiety, negative mood, depression, dry skin, cold intolerance, puffy eyes, muscle cramps and fatigue, deep voice, constipation, slow thinking and poor memory. Clinical manifestations of the disease are defined primarily by low levels of thyroid hormones; therefore it is treated by hormone replacement therapy, which usually consists of levothyroxine (LT<sub>4</sub>). Selenium might reduce antibody levels and result in a decreased dosage of LT<sub>4</sub> and may provide other beneficial effects (e.g. on mood and health‐related quality of life). </p> </section> <section id="CD010223-sec-0002"> <h3 class="title" id="CD010223-sec-0002">Objectives</h3> <p>To assess the effects of selenium supplementation on Hashimoto's thyroiditis.</p> </section> <section id="CD010223-sec-0003"> <h3 class="title" id="CD010223-sec-0003">Search methods</h3> <p>We searched the following databases up to 2 October 2012: CENTRAL in <i>The Cochrane Library</i> (2012, Issue 10), MEDLINE, EMBASE, and Web of Science; we also screened reference lists of included studies and searched several online trial registries for ongoing trials (5 November 2012). </p> </section> <section id="CD010223-sec-0004"> <h3 class="title" id="CD010223-sec-0004">Selection criteria</h3> <p>Randomised controlled clinical trials that assessed the effects of selenium supplementation for adults diagnosed with Hashimoto's thyroiditis. </p> </section> <section id="CD010223-sec-0005"> <h3 class="title" id="CD010223-sec-0005">Data collection and analysis</h3> <p>Study selection, data extraction, assessment of risk of bias, and analyses were carried out by two independent review authors. We assessed the quality of the evidence of included studies using GRADE. We were unable to conduct a meta‐analysis because clinical heterogeneity between interventions that were investigated is substantial. </p> </section> <section id="CD010223-sec-0006"> <h3 class="title" id="CD010223-sec-0006">Main results</h3> <p>Four studies at unclear to high risk of bias comprising 463 participants were included. The mean study duration was 7.5 months (range 3 to 18 months). One of our primary outcomes－'change from baseline in health related quality of life'－and two of our secondary outcomes－'change from baseline in LT<sub>4</sub> replacement dosage at end of the study' and 'economic costs'－were not assessed in any of the studies. One study at high risk of bias showed statistically significant improvement in subjective well‐being with sodium selenite 200 μg plus titrated LT<sub>4</sub> compared with placebo plus titrated LT<sub>4</sub> (relative risk (RR) 4.67, 95% confidence interval (CI) 1.61 to 13.50; P = 0.004; 36 participants; number needed to treat (NNT) = 2 (95% CI 2 to 3)). </p> <p>Selenomethionine 200 μg reduced the serum levels of anti‐thyroid peroxidase antibodies compared with placebo in two studies (mean difference (MD) ‐917 U/mL, 95% CI ‐1056 to ‐778; P &lt; 0.001; 85 participants) and (MD ‐345 IU/mL, 95% CI ‐359 to ‐331; P &lt; 0.001; 169 participants). Pooling of the studies was not feasible due to marked clinical heterogeneity (I<sup>2</sup> = 99%). In a further comparison within the first study where selenomethionine was combined with LT<sub>4</sub> the reduction in TPO antibodies was even more noticeable (MD ‐1508 U/mL, 95% CI ‐1671 to ‐1345; P &lt; 0.001; 86 participants). In a third study, where LT<sub>4</sub> was added to both intervention arms, a reduction in serum levels of anti‐thyroid peroxidase antibodies favoured the selenomethionine arm as well (MD ‐235 IU/mL, 95% CI ‐374 to ‐95; P = 0.001; 88 participants). Although the changes from baseline were statistically significant in these three studies, their clinical relevance is unclear. Serum antibodies were not statistically significantly affected in the study comparing sodium selenite 200 μg plus titrated LT<sub>4</sub> with placebo plus titrated LT<sub>4</sub> (MD ‐25, 95% CI ‐181 to 131; P = 0.75; 36 participants). </p> <p>Adverse events were reported in two studies (1 of 85 and 1 of 88 participants, respectively). Selenium supplementation did not appear to have a statistically significant impact on the incidence of adverse events (RR 2.93, 95% CI 0.12 to 70.00; and RR 2.63, 95% CI 0.11 to 62.95). </p> </section> <section id="CD010223-sec-0007"> <h3 class="title" id="CD010223-sec-0007">Authors' conclusions</h3> <p>Results of these four studies show that evidence to support or refute the efficacy of selenium supplementation in people with Hashimoto's thyroiditis is incomplete. The current level of evidence for the efficacy of selenium supplementation in the management of people with Hashimoto's thyroiditis is based on four randomised controlled trials assessed at unclear to high risk of bias; this does not at present allow confident decision making about the use of selenium supplementation for Hashimoto's thyroiditis. This review highlights the need for randomised placebo‐controlled trials to evaluate the effects of selenium in people with Hashimoto's thyroiditis and can ultimately provide reliable evidence to help inform clinical decision making. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010223-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010223-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010223-abs-0008">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010223-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010223-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010223-abs-0012">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD010223-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010223-abs-0009">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010223-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD010223-abs-0013">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010223-abs-0007">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010223-abs-0006" lang="en"> <h3>Selenium supplementation for Hashimoto's thyroiditis</h3> <p>Hashimoto's thyroiditis is a common disease in which a form of chronic inflammation of the thyroid gland results in reduced function of the gland. It is an auto‐immune disorder, which means that a person's own immune system attacks the thyroid gland, so that it no longer makes adequate quantities of thyroid hormones (hypothyroidism). Common clinical manifestations include feeling cold, depressive mood, dry skin, puffy eyes, constipation, weight gain, slowed heart rate, joint and muscle pain and fatigue. Some but not all people with Hashimoto's thyroiditis have an enlarged gland, also called a <i>goitre</i>. Hashimoto's thyroiditis is more common in women than in men and tends to run in families. Other auto‐immune diseases often occur simultaneously, such as vitiligo, rheumatoid arthritis and diabetes type 1. The disease does not always require treatment, but when it does, it is treated with synthetic thyroid hormone replacement (sometimes desiccated thyroid hormone is used, which is not synthetic). Selenium is an essential trace element that is required in small amounts for correct functioning of the immune system and the thyroid gland. </p> <p>Four studies at unclear to high risk of bias comprising 463 participants were included. The mean study duration was 7.5 months (range 3 to 18 months). None of the studies addressed our key primary outcome－'health‐related quality of life'. Two of our secondary outcomes－'change from baseline in levothyroxine (i.e. thyroid hormone) replacement dosage at end of the study' and 'economic costs'－were not assessed either. One study at high risk of bias showed a statistically significant improvement in subjective well‐being with sodium selenite 200 μg plus levothyroxine compared with placebo plus levothyroxine (14/18 compared with 3/18, respectively). Selenomethionine 200 μg reduced the serum levels of anti‐thyroid peroxidase antibodies in three studies, and although the changes from baseline were statistically significant, their clinical relevance is unclear. Adverse events were reported in two studies, and selenium supplementation did not lead to more adverse events than were seen with placebo. One adverse event was reported in both studies in the selenomethionine 200 μg plus LT<sub>4</sub> arm versus none in the control arm. </p> <p>In conclusion, the results of these four studies do not provide enough evidence to support the use of selenium in the treatment of Hashimoto's thyroiditis. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010223-sec-0150" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010223-sec-0150"></div> <h3 class="title" id="CD010223-sec-0151">Implications for practice</h3> <section id="CD010223-sec-0151"> <p>The results of this review demonstrate that at present, objective evidence is insufficient to support clinical decision making regarding the use of selenium supplementation for the treatment of patients with Hashimoto's thyroiditis. </p> </section> <h3 class="title" id="CD010223-sec-0152">Implications for research</h3> <section id="CD010223-sec-0152"> <p>This review highlights the need for randomised placebo‐controlled trials to evaluate the effects of selenium in people with Hashimoto's thyroiditis, which can ultimately provide reliable evidence to support clinical decision making.<br/> Any future randomised controlled trials must be well designed, well conducted and adequately delivered with subsequent reporting, including high‐quality descriptions of all aspects of methodology. Reporting should conform to the Consolidated Standards of Reporting Trials (CONSORT) statement (<a href="http://www.consort-statement.org/" target="_blank">http://www.consort‐statement.org/</a>); this will promote appraisal and interpretation of results and accurate judgement of risk of bias and of the overall quality of the evidence.<br/> Although it is uncertain whether reported quality mirrors actual study conduct, it is noteworthy that studies with unclear methodology have been shown to produce biased estimates of treatment effects (<a href="./references#CD010223-bbs2-0048" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA1995;273(5):408‐12. [PUBMED: PMID: 7823387] ">Schulz 1995</a>). </p> <p>For further research recommendations based on the EPICOT (evidence, population, intervention, comparison, outcomes, and time) format (<a href="./references#CD010223-bbs2-0017" title="BrownP , BrunnhuberK , ChalkidouK , ChalmersI , ClarkeM , FentonM , et al. How to formulate research recommendations. British Medical Journal2006;333(7572):804‐6. ">Brown 2006</a>), see <a href="#CD010223-tbl-0004">Table 3</a>. </p> <div class="table" id="CD010223-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Research recommendations based on a gap in the evidence of the effects of selenium for Hashimoto's thyroiditis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Core elements</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Issues to consider</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Status of research for this review</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Evidence (E)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>What is the current state of the evidence?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This systematic review identified one randomised controlled trial (RCT). Incomplete evidence of efficacy and safety of selenium for Hashimoto's thyroiditis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Population (P)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis, disease stage, co‐morbidity, risk factors, gender, age, ethnic group, specific inclusion or exclusion criteria, clinical setting </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inclusion criteria: </p> <p> <ul id="CD010223-list-0013"> <li> <p>Hashimoto's thyroiditis as diagnosed by a physician and supported by serum levels of anti‐TPOAb and anti‐TgAb above the normal level of the laboratory's normal ranges. </p> </li> </ul> </p> <p>Exclusion criteria: </p> <p> <ul id="CD010223-list-0014"> <li> <p>Clinical history of hyperthyroidism.</p> </li> <li> <p>Any acute and chronic inflammatory processes.</p> </li> <li> <p>Drugs known to induce thyroid dysfunction (cytokines, lithium, amiodarone).</p> </li> <li> <p>Concomitant treatment with drugs that may affect inflammatory processes in the vascular wall. </p> </li> <li> <p>Pregnancy in the last 12 month before enrolment.</p> </li> <li> <p>No further treatment such as over‐the‐counter vitamins or trace elements or corticoid or anti‐inflammatory therapy. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention (I)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Type, frequency, dose, duration, prognostic factor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Selenium 100 µg or 200 µg supplementation (sodium selenite or selenomethionine) plus titrated LT<sub>4</sub> to maintain basal TSH within normal range for at least 3 months. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparison (C)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Type, frequency, dose, duration, prognostic factor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD010223-list-0015"> <li> <p>No control plus titrated LT<sub>4</sub> to maintain basal TSH within normal range for at least 3 months. </p> </li> </ul> <ul id="CD010223-list-0016"> <li> <p>Placebo tablets plus titrated LT<sub>4</sub> to maintain basal TSH within normal range for at least 3 months. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome (O)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Which clinical or patient‐related outcomes will the researcher need to measure, improve, influence or accomplish? Which methods of measurement should be used? </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcomes  </p> <p> <ul id="CD010223-list-0017"> <li> <p>Change from baseline in HRQoL assessed using any validated quality‐of‐life instrument at end of study. </p> </li> <li> <p>Change from baseline in symptoms such as mood, fatigue and muscle weakness assessed using any validated instrument at end of study. </p> </li> <li> <p>Proportions of participants reporting an adverse event throughout the study period.</p> </li> </ul> </p> <p>Secondary outcomes  </p> <p> <ul id="CD010223-list-0018"> <li> <p>Change from baseline in serum levels of anti‐thyroid peroxidase antibodies at end of study. </p> </li> <li> <p>Change from baseline in LT<sub>4</sub> replacement dosage at end of study. </p> </li> <li> <p>Economic costs.</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time Stamp (T)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Date of literature search or recommendation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 November 2012</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study Type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>What is the most appropriate study design to address the proposed question?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD010223-list-0019"> <li> <p>RCT (adequately powered/multi‐centred).</p> </li> <li> <p>Methods: concealment of allocation sequence.</p> </li> <li> <p>Blinding: blinding of participants, trialists and outcomes assessors.</p> </li> <li> <p>Setting: hospital/university.</p> </li> </ul> </p> </td> </tr> </tbody> </table> </div> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010223-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010223-sec-0036"></div> <div class="table" id="CD010223-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Selenium (+LT4) compared to placebo (+LT4) for participants with Hashimoto's thyroiditis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Selenium (+LT<sub>4</sub>) compared with placebo (+LT<sub>4</sub>) for participants with Hashimoto's thyroiditis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with Hashimoto's thyroiditis.<br/> <b>Settings:</b> hospital outpatient department.<br/> <b>Intervention:</b> selenium (+ levothyroxine)<sup>a.</sup> <br/> <b>Comparison:</b> placebo (+ levothyroxine). </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo (+ levothyroxine)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Selenium <br/> (+ levothyroxine)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change from baseline in health‐related quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported in any study</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change from baseline in assessment of symptoms such as mood, fatigue and muscle weakness</b> <br/> Short‐Form Health Survey<br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>167 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>778 per 1000</b> <br/> (268 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 4.67</b> <br/> (1.61 to 13.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>low</b><sup>b,c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of participants reporting an adverse event</b> <br/> Follow‐up: mean 5 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.71</b> <br/> (0.29 to 25.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>258<br/> (3 studies<sup>e</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants in placebo group counted twice (same participants in both comparisons)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change from baseline in serum levels of anti‐thyroid peroxidase antibodies</b> <br/> Decrease from 1508 to 25 IU/L<br/> Follow‐up: mean 4.5 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>252<br/> (4 studies<sup>e</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data could not be pooled because of substantial clinical heterogeneity of participants, interventions and controls </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change from baseline in LT<sub>4</sub> replacement dosage at end of study</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported in any study</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Economic costs</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported in any study</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence:<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a> and <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a> included levothyroxine in both treatment arms. <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a> included levothyroxine in one arm combined with selenium.<br/> <sup>b</sup>Randomisation was probably based on prognostic factors, and no mention was made of stratified randomisation.<br/> <sup>c</sup>Wide confidence interval.<br/> <sup>d</sup>RR 4.67.<br/> <sup>e</sup>One study provided two comparisons. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010223-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010223-sec-0037"></div> <p>Unfamiliar terms are listed in the 'Glossary of terms' (<a href="#CD010223-tbl-0002">Table 1</a>). </p> <div class="table" id="CD010223-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Explanation</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Auto‐antigen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usually a normal protein or complex of proteins (sometimes deoxyribonucleic acid (DNA) or ribonucleic acid (RNA)) that is recognised by the immune system of patients suffering from a specific auto‐immune disease. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Antibody</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Produced by immune cells, B cells, to identify and neutralise foreign objects such as bacteria and viruses. The antibody recognises a unique part of the foreign target, called an <i>antigen</i>; this might also be an auto‐antigen. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Atherosclerosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A condition in which an artery wall thickens as a result of the accumulation of fatty materials such as cholesterol. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Biosynthesis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An enzyme‐catalysed process in cells of living organisms by which substrates are converted to more complex products. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cytokines</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small protein molecules, secreted by several types of cells to stimulate other cells.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CD4+ T‐helper cells</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A subgroup of T‐cell lymphocytes, a type of white blood cell that plays an important role in the immune system, particularly the adaptive immune system. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CD8+ cytotoxic T cells</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A subgroup of T‐cell lymphocytes that induce the death of cells infected with viruses (and other pathogens) or otherwise damaged or dysfunctional. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dyslipidaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High cholesterol or fat levels in the blood.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Goitre</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A swelling in the thyroid gland.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GPx4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Phospholipid hydroperoxide glutathione peroxidase, a selenoprotein enzyme.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GPx</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Glutathione peroxidase, a selenoprotein enzyme that has an antioxidant function.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Homeostasis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A state of balanced levels of the molecule in the human body.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hyperglycaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High glucose levels in the blood.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IFN‐γ</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interferon‐gamma; a cytokine or type II interferon that is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumour control. Aberrant IFN‐γ expression is associated with a number of auto‐inflammatory and auto‐immune diseases. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LDL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low‐density lipoproteins or 'bad' cholesterol.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Macrophage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A type of immune cell that differentiates from monocytes in tissue and phagocytises (engulfs) foreign materials. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pancreatitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inflammation of the pancreas.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rheumatoid arthritis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A chronic, systemic inflammatory disorder that may affect many tissues and organs but principally attacks flexible (synovial) joints. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selenoprotein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selenium incorporated into proteins.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Stroke</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A condition of impaired blood supply to the brain resulting in rapid loss of brain function(s). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thyrocyte</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thyroid gland epithelial cells.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitiligo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An auto‐immune disorder that affects the skin, causing loss of pigment.</p> </td> </tr> </tbody> </table> </div> <section id="CD010223-sec-0038"> <h3 class="title" id="CD010223-sec-0038">Description of the condition</h3> <p>Hashimoto's thyroiditis (HT) or chronic lymphocytic thyroiditis is a common auto‐immune disorder. HT tends to run in families and affects women and men of all ages, although it is most often seen in middle‐aged women (<a href="./references#CD010223-bbs2-0027" title="FinkH , HintzeG . Autoimmune thyroiditis (Hashimoto's thyroiditis): current diagnostics and therapy [Die Autoimmunthyreoiditis (Hashimoto‐Thyreoiditis): aktuelle Diagnostik und Therapie]. Medizinische Klinik2010;105(7):485‐93. ">Fink 2010</a>; <a href="./references#CD010223-bbs2-0050" title="StathatosN , DanielsGH . Autoimmune thyroid disease. Current Opinion in Rheumatology2012;24(1):70‐5. [PUBMED: PMID: 22157414] ">Stathatos 2012</a>). Its prevalence is influenced by ethnicity, environmental factors such as iodine and selenium status, age and gender (<a href="./references#CD010223-bbs2-0027" title="FinkH , HintzeG . Autoimmune thyroiditis (Hashimoto's thyroiditis): current diagnostics and therapy [Die Autoimmunthyreoiditis (Hashimoto‐Thyreoiditis): aktuelle Diagnostik und Therapie]. Medizinische Klinik2010;105(7):485‐93. ">Fink 2010</a>; <a href="./references#CD010223-bbs2-0050" title="StathatosN , DanielsGH . Autoimmune thyroid disease. Current Opinion in Rheumatology2012;24(1):70‐5. [PUBMED: PMID: 22157414] ">Stathatos 2012</a>). Although data on its prevalence are limited at a global level, HT is estimated to affect 1% to 2% of adult women in the US (<a href="./references#CD010223-bbs2-0033" title="HutflessS , MatosP , TalorMV , CaturegliP , RoseNR . Significance of prediagnostic thyroid antibodies in women with autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism2011;96(9):E1466‐71. [PUBMED: PMID:21715532] ">Hutfless 2011</a>; <a href="./references#CD010223-bbs2-0049" title="StaiiA , MirochaS , Todorova‐KotevaK , GlinbergS , JaumeJC . Hashimoto thyroiditis is more frequent than expected when diagnosed by cytology which uncovers a pre‐clinical state. Thyroid Research2010;3(1):11. [PUBMED: PMID: 21172028] ">Staii 2010</a>) and is the most common cause of hypothyroidism in iodine‐sufficient areas of the world. However, subclinical hypothyroidism is more prevalent and occurs in 3% of men and approximately 8% to 10% of women (<a href="./references#CD010223-bbs2-0021" title="ChistiakovDA . Immunogenetics of Hashimoto's thyroiditis. Journal of Autoimmune Diseases2005;2(1):1. [PUBMED: PMID: 15762980] ">Chistiakov 2005</a>). Concomitant and other auto‐immune diseases such as rheumatoid arthritis, diabetes mellitus type 1, multiple sclerosis and celiac disease are frequently seen in people suffering from HT (<a href="./references#CD010223-bbs2-0021" title="ChistiakovDA . Immunogenetics of Hashimoto's thyroiditis. Journal of Autoimmune Diseases2005;2(1):1. [PUBMED: PMID: 15762980] ">Chistiakov 2005</a>; <a href="./references#CD010223-bbs2-0050" title="StathatosN , DanielsGH . Autoimmune thyroid disease. Current Opinion in Rheumatology2012;24(1):70‐5. [PUBMED: PMID: 22157414] ">Stathatos 2012</a>). </p> <p>The most common presenting symptoms may include anxiety, negative mood, depression, dry skin, cold intolerance, puffy eyes, muscle cramps and fatigue, deep voice, constipation, slow thinking and poor memory (<a href="./references#CD010223-bbs2-0019" title="CanarisGJ , ManowitzNR , MayorG , RidgwayEC . The Colorado thyroid disease prevalence study. Archives of Internal Medicine2000;160(4):526‐34. [PUBMED: PMID: 10695693] ">Canaris 2000</a>; <a href="./references#CD010223-bbs2-0020" title="CartaMG , LoviselliA , HardoyMC , MassaS , CadedduM , SarduC , et al. The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future. BMC Psychiatry2004;18(4):25. [PUBMED: PMID: 15317653] ">Carta 2004</a>). The thyroid gland may enlarge and may present in its classical form as goitre; although thyroid enlargement is usually asymptomatic, a few patients have described thyroid pain and tenderness, sometimes requiring surgical intervention (<a href="./references#CD010223-bbs2-0038" title="LiY , NishiharaE , KakudoK . Hashimoto's thyroiditis: old concepts and new insights. Current Opinion in Rheumatology2011;23(1):102‐7. [PUBMED: PMID: 21124092] ">Li 2011</a>). The other major form of HT, not presenting with goitre, is atrophic auto‐immune thyroiditis, in which fibrosis is more dominant (<a href="./references#CD010223-bbs2-0018" title="Bülow PedersenI , LaurbergP , KnudsenN , JørgensenT , PerrildH , OvesenL , et al. A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure. Clinical Endocrinology2005;62(6):713‐20. [PUBMED: PMID: 15943834] ">Bülow Pedersen 2005</a>). Variant forms of the disorder include silent (painless) thyroiditis and postpartum thyroiditis, both of which are transient but may be followed years later by thyroid failure (<a href="./references#CD010223-bbs2-0037" title="LazarusJH , HallR , OthmanS , ParkesAB , RichardsCJ , McCullochB , et al. The clinical spectrum of postpartum thyroid disease. QJM1996;89(6):429‐35. [PUBMED: PMID: 8758046] ">Lazarus 1996</a>; <a href="./references#CD010223-bbs2-0044" title="PearceEN , FarwellAP , BravermanLE . Thyroiditis. New England Journal of Medicine2003;348(26):2646‐55. [PUBMED: PMID: 12826640] ">Pearce 2003</a>). Hypothyroidism due to HT in pregnant women is frequently associated with increased perinatal morbidity, miscarriage, postpartum thyroiditis and impaired neuropsychological development of the infant (<a href="./references#CD010223-bbs2-0022" title="DosiouC , BarnesJ , SchwartzA , NegroR , CrapoL , Stagnaro‐GreenA . Cost‐effectiveness of universal and risk‐based screening for autoimmune thyroid disease in pregnant women. Journal of Clinical Endocrinology and Metabolism2012;97(5):1536‐46. [PUBMED: PMID: 22399510] ">Dosiou 2012</a>; <a href="./references#CD010223-bbs2-0050" title="StathatosN , DanielsGH . Autoimmune thyroid disease. Current Opinion in Rheumatology2012;24(1):70‐5. [PUBMED: PMID: 22157414] ">Stathatos 2012</a>). </p> <p>Although hypothyroidism is the characteristic functional abnormality of HT, the inflammatory process early in the course sometimes involves enough apoptosis to cause thyroid follicular disruption and thyroid hormone release, inducing transient hyperthyroidism (<a href="./references#CD010223-bbs2-0026" title="FatourechiV , McConaheyWM , WoolnerLB . Hyperthyroidism associated with histologic Hashimoto's thyroiditis. Mayo Clinic Proceedings1971;46(10):682‐9. [PUBMED: PMID: 5171000] ">Fatourechi 1971</a>). In rare cases, patients may cycle between hypothyroidism and Graves' disease (<a href="./references#CD010223-bbs2-0035" title="KraiemZ , BaronE , KahanaL , SadehO , SheinfeldM . Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper‐thyroidism and back to hypothyroidism. Clinical Endocrinology1992;36(2):211‐4. [PUBMED: PMID: 1637398] ">Kraiem 1992</a>; <a href="./references#CD010223-bbs2-0054" title="TakasuN , YamadaT , SatoA , NakagawaM , KomiyaI , NagasawaY , et al. Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases. Clinical Endocrinology1990;33(6):687‐98. [PUBMED: PMID: 1982861] ">Takasu 1990</a>). The usual course of HT involves gradual loss of thyroid function. Patients who have mild (subclinical) hypothyroidism show overt hypothyroidism at a rate of approximately 5% per year (<a href="./references#CD010223-bbs2-0032" title="HuberG , StaubJJ , MeierC , MitracheC , GuglielmettiM , HuberP , et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. Journal of Clinical Endocrinology and Metabolism2002;87(7):3221‐6. [PUBMED: PMID: 12107228] ">Huber 2002</a>). Overt hypothyroidism, once present, is permanent in nearly all cases, except in some children and postpartum women in whom it is often transient. </p> <p>Specific serum auto‐antibodies such as anti‐thyroid peroxidase antibodies (anti‐TPOAb) and anti‐thyroglobulin antibodies (anti‐TgAb) are characteristic of HT; serum thyroxine (T<sub>4</sub>) may be normal or low, and thyroid‐stimulating hormone (TSH) concentrations may be normal or high (<a href="./references#CD010223-bbs2-0038" title="LiY , NishiharaE , KakudoK . Hashimoto's thyroiditis: old concepts and new insights. Current Opinion in Rheumatology2011;23(1):102‐7. [PUBMED: PMID: 21124092] ">Li 2011</a>). Histopathologic examination merely shows diffuse lymphocytic infiltration and formation of germinal centres, although fibrosis can also be detected (<a href="./references#CD010223-bbs2-0038" title="LiY , NishiharaE , KakudoK . Hashimoto's thyroiditis: old concepts and new insights. Current Opinion in Rheumatology2011;23(1):102‐7. [PUBMED: PMID: 21124092] ">Li 2011</a>; <a href="./references#CD010223-bbs2-0053" title="StuartA . The changing scene in Hashimoto's disease: a review. Medical Hypotheses2011;77:424‐6. [PUBMED: PMID: 21741770] ">Stuart 2011</a>). </p> <p>Clinical manifestations of the disease are defined primarily by low levels of thyroid hormones; therefore patients are treated by hormone replacement therapy, which usually consists of levothyroxine (LT<sub>4</sub>) (<a href="./references#CD010223-bbs2-0057" title="ÖzenS , BerkÖ , ŞimşekDG , DarcanS . Clinical course of Hashimoto's thyroiditis and effects of levothyroxine therapy on the clinical course of the disease in children and adolescents. Journal of Clinical Research in Pediatric Endocrinology2011;3(4):192‐7. [PUBMED: PMID: 22155461] ">Özen 2011</a>). </p> <section id="CD010223-sec-0039"> <h4 class="title">Pathogenesis</h4> <p>In HT, thyrocytes are attacked by a variety of cell‐ and antibody‐mediated inflammatory reactions, resulting in low levels of thyroid hormone (<a href="./references#CD010223-bbs2-0041" title="MitchellRN , KumarV , AbbasAK , FaustoN . The endocrine system. In: AlpersCE , AnthonyDC , AsterJC , CrawfordJM , CrumCP , et al. editor(s). Robbins and Cotran Pathologic Basis of Disease. 8th Edition. Philadelphia, Pa: Elsevier, 2007:758‐60. ">Mitchell 2007</a>). Auto‐immunity can develop from the interaction of genetic susceptibility and environmental and endogenous factors (<a href="./references#CD010223-bbs2-0021" title="ChistiakovDA . Immunogenetics of Hashimoto's thyroiditis. Journal of Autoimmune Diseases2005;2(1):1. [PUBMED: PMID: 15762980] ">Chistiakov 2005</a>; <a href="./references#CD010223-bbs2-0047" title="SaranacL , ZivanovicS , BjelakovicB , StamenkovicH , NovakM , KamenovB . Why is the thyroid so prone to autoimmune disease?. Hormone Research in Paediatrics2011;75(3):157‐65. [PUBMED: PMID: 21346360] ">Saranac 2011</a>; <a href="./references#CD010223-bbs2-0055" title="TomerY . Genetic dissection of familial autoimmune thyroid diseases using whole genome screening. Autoimmunity Reviews2002;1(4):198‐204. [PUBMED: PMID: 12848996] ">Tomer 2002</a>). Several susceptibility genes have been identified, such as <i>HLA‐DR, CD‐40, CTLA‐4, PTPN‐22</i> and thyroid‐specific genes (i.e. thyroglobulin and TSH receptor genes) (<a href="./references#CD010223-bbs2-0047" title="SaranacL , ZivanovicS , BjelakovicB , StamenkovicH , NovakM , KamenovB . Why is the thyroid so prone to autoimmune disease?. Hormone Research in Paediatrics2011;75(3):157‐65. [PUBMED: PMID: 21346360] ">Saranac 2011</a>; <a href="./references#CD010223-bbs2-0050" title="StathatosN , DanielsGH . Autoimmune thyroid disease. Current Opinion in Rheumatology2012;24(1):70‐5. [PUBMED: PMID: 22157414] ">Stathatos 2012</a>). Auto‐antigens, including tissue‐specific membrane receptors, enzymes and hormones, are presented by major histocompatibility complex (MHC) class II antigen‐presenting cells (APCs) to naive T cells and infiltrate the thyroid gland. Environmental factors such as high iodine intake, selenium deficiency and viral infection can increase the likelihood of this infiltration followed by clonal expansion of both T and B lymphocytes in the draining lymph nodes (<a href="./references#CD010223-bbs2-0021" title="ChistiakovDA . Immunogenetics of Hashimoto's thyroiditis. Journal of Autoimmune Diseases2005;2(1):1. [PUBMED: PMID: 15762980] ">Chistiakov 2005</a>; <a href="./references#CD010223-bbs2-0047" title="SaranacL , ZivanovicS , BjelakovicB , StamenkovicH , NovakM , KamenovB . Why is the thyroid so prone to autoimmune disease?. Hormone Research in Paediatrics2011;75(3):157‐65. [PUBMED: PMID: 21346360] ">Saranac 2011</a>). Activated CD4+ T‐helper cells promote the release of interferon‐gamma (INF‐γ) by CD8+ cytotoxic T cells; this activates macrophages that capture the damaged thyroid cells, resulting in cytokine‐mediated cell death. In addition, auto‐antibodies (anti‐TSH receptor antibodies, anti‐thyroglobulin and anti‐TPOAb) produced by B cells cause antibody‐mediated cell death (<a href="./references#CD010223-bbs2-0041" title="MitchellRN , KumarV , AbbasAK , FaustoN . The endocrine system. In: AlpersCE , AnthonyDC , AsterJC , CrawfordJM , CrumCP , et al. editor(s). Robbins and Cotran Pathologic Basis of Disease. 8th Edition. Philadelphia, Pa: Elsevier, 2007:758‐60. ">Mitchell 2007</a>). The end result consists of a gradual depletion of thyrocytes and replacement by mononuclear cell infiltration and diffuse fibrosis (<a href="./references#CD010223-bbs2-0041" title="MitchellRN , KumarV , AbbasAK , FaustoN . The endocrine system. In: AlpersCE , AnthonyDC , AsterJC , CrawfordJM , CrumCP , et al. editor(s). Robbins and Cotran Pathologic Basis of Disease. 8th Edition. Philadelphia, Pa: Elsevier, 2007:758‐60. ">Mitchell 2007</a>). </p> </section> </section> <section id="CD010223-sec-0040"> <h3 class="title" id="CD010223-sec-0040">Description of the intervention</h3> <p>Selenium is an essential trace element that is required in small amounts for correct functioning of the immune system. The recommended daily intake for adults is 55 μg/day (<a href="./references#CD010223-bbs2-0031" title="HuY , McIntoshGH , YoungGP . Selenium‐rich foods: a promising approach to colorectal cancer prevention. Current Pharmaceutical Biotechnology2012;13(1):165‐72. [PUBMED: PMID: 21466436] ">Hu 2012</a>). It is obtained from natural selenium rich sources such as brazil nuts, organ meat, muscle meat, cereals, shellfish and fish (<a href="./references#CD010223-bbs2-0045" title="RaymanMP . Food‐chain selenium and human health: emphasis on intake. The British Journal of Nutrition2008;100(2):254‐68. [PUBMED: PMID: 18346308] ">Rayman 2008</a>). The selenium content of food depends on local soil conditions, which can vary depending on geographical and geological factors (<a href="./references#CD010223-bbs2-0045" title="RaymanMP . Food‐chain selenium and human health: emphasis on intake. The British Journal of Nutrition2008;100(2):254‐68. [PUBMED: PMID: 18346308] ">Rayman 2008</a>). The serum selenium concentration is believed to be in the 70 to 130 ng/mL range (<a href="./references#CD010223-bbs2-0015" title="BleysJ , Navas‐AcienA , GuallarE . Serum selenium levels and all‐cause, cancer, and cardiovascular mortality among US adults. Archives of Internal Medicine2008;168(4):404‐10. [PUBMED: PMID: 18299496] ">Bleys 2008</a>). Selenomethionine and sodium selenite are the two most common oral forms of selenium supplementation that are available in variable dosages (100 and 200 μg/day) and are usually taken for HT (<a href="./references#CD010223-bbs2-0056" title="ToulisKA , AnastasilakisAD , TzellosTG , GoulisDG , KouvelasD . Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta‐analysis. Thyroid2010;20(10):1163‐73. [PUBMED: PMID: 20883174] ">Toulis 2010</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>). </p> <section id="CD010223-sec-0041"> <h4 class="title">Adverse effects of the intervention</h4> <p>The upper tolerable intake level of selenium is 400 μg/day (<a href="./references#CD010223-bbs2-0045" title="RaymanMP . Food‐chain selenium and human health: emphasis on intake. The British Journal of Nutrition2008;100(2):254‐68. [PUBMED: PMID: 18346308] ">Rayman 2008</a>). Therefore, oral doses of selenium of less than 400 μg/day will not result in serious adverse effects over the short term (<a href="./references#CD010223-bbs2-0042" title="MonsenER . Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids. Journal of the American Dietetic Association2000;100(6):637‐40. [PUBMED: PMID: 10863565] ">Monsen 2000</a>). However, several adverse effects have been recorded with higher doses, resulting in chronic toxicity or selenosis (e.g. gastrointestinal upset, hair loss, white blotchy nails, garlic breath odour, fatigue, irritability, mild nerve damage) (<a href="./references#CD010223-bbs2-0028" title="GoldhaberSB . Trace element risk assessment: essentiality vs. toxicity. Regulatory Toxicology and Pharmacology2003;38(2):232‐42. [PUBMED: PMID: 14550763] ">Goldhaber 2003</a>; <a href="./references#CD010223-bbs2-0045" title="RaymanMP . Food‐chain selenium and human health: emphasis on intake. The British Journal of Nutrition2008;100(2):254‐68. [PUBMED: PMID: 18346308] ">Rayman 2008</a>). It has also been reported that selenium may increase the likelihood of type 2 diabetes (<a href="./references#CD010223-bbs2-0051" title="StrangesS , MarshallJR , NatarajanR , DonahueRP , TrevisanM , CombsGF , et al. Effects of long‐term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Annals of Internal Medicine2007;147(4):217‐23. [PUBMED: PMID: 17620655] ">Stranges 2007</a>). The suggested mechanism is that selenium may suppress the production of insulin‐like growth factor‐1 (i.e. influencing glucose homeostasis). Moreover, selenium in high levels may promote the release of glucagon, resulting in hyperglycaemia (<a href="./references#CD010223-bbs2-0051" title="StrangesS , MarshallJR , NatarajanR , DonahueRP , TrevisanM , CombsGF , et al. Effects of long‐term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Annals of Internal Medicine2007;147(4):217‐23. [PUBMED: PMID: 17620655] ">Stranges 2007</a>). Likewise, high selenium blood levels may contribute to dyslipidaemia. The potential mechanism is not fully understood, but it has been proposed that elevated levels of selenium might result in high levels of selenoproteins that regulate cholesterol biosynthesis (<a href="./references#CD010223-bbs2-0052" title="StrangesS , LaclaustraM , JiC , CappuccioFP , Navas‐AcienA , OrdovasJM , et al. Higher selenium status is associated with adverse blood lipid profile in British adults. Journal of Nutrition2010;140(1):81‐7. [PUBMED: PMID: 19906812] ">Stranges 2010</a>). </p> </section> </section> <section id="CD010223-sec-0042"> <h3 class="title" id="CD010223-sec-0042">How the intervention might work</h3> <p>Recent advances in thyroid cell physiology have illustrated the key role that selenium plays in thyroid gland function (<a href="./references#CD010223-bbs2-0036" title="KöhrleJ , JakobF , ContempréB , DumontJE . Selenium, the thyroid, and the endocrine system. Endocrine Reviews2005;26(7):944‐84. [PUBMED: PMID: 16174820] ">Köhrle 2005</a>). Several enzymes in the thyroid gland are selenoproteins, meaning that selenium is incorporated in their molecular structure (<a href="./references#CD010223-bbs2-0016" title="BrownKM , ArthurJR . Selenium, selenoproteins and human health: a review. Public Health Nutrition2001;4(2B):593‐9. [PUBMED: PMID: 11683552] ">Brown 2001</a>; <a href="./references#CD010223-bbs2-0036" title="KöhrleJ , JakobF , ContempréB , DumontJE . Selenium, the thyroid, and the endocrine system. Endocrine Reviews2005;26(7):944‐84. [PUBMED: PMID: 16174820] ">Köhrle 2005</a>). One of the most vital of these enzymes, glutathione peroxidase (GPx), is involved in protecting the gland against oxidative damage. Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), a free radical capable of inflicting oxidative damage, is required as substrate by thyroid peroxidase (TPO) for the iodination and coupling of tyrosyl residues in thyroglobulin to produce thyroid hormone. The active form of thyroid hormone, triiodothyronine (T<sub>3</sub>), is produced by de‐iodination of the prohormone T<sub>4</sub> by type I and type II iodothyronine de‐iodinases (IDIs) in a two‐substrate 'ping‐pong' mechanism of reaction, along with degradation of H<sub>2</sub>O<sub>2</sub> to water by GPx. IDIs, such as GPx, are also selenoproteins. If a selenium deficiency exists, these two enzymes cannot function properly, and the end result is ineffective production of T<sub>3</sub> and inefficient protection against free radicals, inducing cell damage and auto‐immune destruction of the gland (<a href="./references#CD010223-bbs2-0016" title="BrownKM , ArthurJR . Selenium, selenoproteins and human health: a review. Public Health Nutrition2001;4(2B):593‐9. [PUBMED: PMID: 11683552] ">Brown 2001</a>; <a href="./references#CD010223-bbs2-0036" title="KöhrleJ , JakobF , ContempréB , DumontJE . Selenium, the thyroid, and the endocrine system. Endocrine Reviews2005;26(7):944‐84. [PUBMED: PMID: 16174820] ">Köhrle 2005</a>; <a href="./references#CD010223-bbs2-0056" title="ToulisKA , AnastasilakisAD , TzellosTG , GoulisDG , KouvelasD . Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta‐analysis. Thyroid2010;20(10):1163‐73. [PUBMED: PMID: 20883174] ">Toulis 2010</a>). In these conditions, selenium supplementation may be of benefit to patients with HT (<a href="./references#CD010223-bbs2-0056" title="ToulisKA , AnastasilakisAD , TzellosTG , GoulisDG , KouvelasD . Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta‐analysis. Thyroid2010;20(10):1163‐73. [PUBMED: PMID: 20883174] ">Toulis 2010</a>). </p> </section> <section id="CD010223-sec-0043"> <h3 class="title" id="CD010223-sec-0043">Why it is important to do this review</h3> <p>Several studies have suggested that selenium supplementation in patients with HT reduces antibodies levels (<a href="./references#CD010223-bbs2-0008" title="GärtnerR , GasnierBC , DietrichJW , KrebsB , AngstwurmMW . Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. Journal of Clinical Endocrinology and Metabolism2002;87(4):1687‐91. [PUBMED: PMID: 11932302] ">Gärtner 2002</a>), results in a decreased dosage of LT<sub>4</sub> and may provide other beneficial effects (e.g. on mood and health‐related quality of life (HRQoL)) (<a href="./references#CD010223-bbs2-0043" title="OttJ , PrombergerR , KoberF , NeuholdN , TeaM , HuberJC , et al. Hashimoto's thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case‐control study in women undergoing thyroidectomy for benign goiter. Thyroid2011;21(2):161‐7. [PUBMED: PMID: 21186954] ">Ott 2011</a>). On the basis of the last date of searches in 2007, one systematic review (<a href="./references#CD010223-bbs2-0056" title="ToulisKA , AnastasilakisAD , TzellosTG , GoulisDG , KouvelasD . Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta‐analysis. Thyroid2010;20(10):1163‐73. [PUBMED: PMID: 20883174] ">Toulis 2010</a>) concluded that high‐level evidence of the benefits of selenium supplementation for periods longer than three months is limited. The review authors also highlighted a lack of "meaningful clinical outcomes" selected and reported in the included trials; therefore at that time, routine selenium supplementation could not be recommended for HT. This previous review is discussed further in the section, '<a href="#CD010223-sec-0149">Agreements and disagreements with other studies or reviews</a>'.   </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010223-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010223-sec-0044"></div> <p>To assess the effects of selenium supplementation for Hashimoto's thyroiditis.</p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010223-sec-0045" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010223-sec-0045"></div> <section id="CD010223-sec-0046"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010223-sec-0047"> <h4 class="title">Types of studies</h4> <p>Randomised controlled clinical trials.</p> </section> <section id="CD010223-sec-0048"> <h4 class="title">Types of participants</h4> <p>Adults (18 years of age and older) diagnosed with Hashimoto's thyroiditis.</p> <section id="CD010223-sec-0049"> <h5 class="title">Diagnostic criteria</h5> <p>As diagnosed by a physician and supported by serum levels of anti‐TPOAb and anti‐TgAb above the normal level of the laboratory's normal range. </p> </section> </section> <section id="CD010223-sec-0050"> <h4 class="title">Types of interventions</h4> <section id="CD010223-sec-0051"> <h5 class="title">Intervention</h5> <p> <ul id="CD010223-list-0001"> <li> <p>Selenium 100 µg or 200 µg supplementation (sodium selenite or selenomethionine) alone or combined with titrated LT<sub>4</sub> to maintain basal TSH within normal range. </p> </li> </ul> </p> </section> <section id="CD010223-sec-0052"> <h5 class="title">Control</h5> <p> <ul id="CD010223-list-0002"> <li> <p>No control or no control plus titrated LT<sub>4</sub> to maintain basal TSH within the normal range. </p> </li> <li> <p>Placebo tablets or placebo tablets plus titrated LT<sub>4</sub> to maintain basal TSH within the normal range. </p> </li> </ul> </p> </section> </section> <section id="CD010223-sec-0053"> <h4 class="title">Types of outcome measures</h4> <section id="CD010223-sec-0054"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010223-list-0003"> <li> <p>Change from baseline in HRQoL assessed using any validated quality‐of‐life instrument at end of study. </p> </li> <li> <p>Change from baseline in symptoms such as mood, fatigue and muscle weakness assessed using any validated instrument at end of study. </p> </li> <li> <p>Proportion of participants reporting an adverse event throughout the study period.</p> </li> </ul> </p> </section> <section id="CD010223-sec-0055"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010223-list-0004"> <li> <p>Change from baseline in serum levels of anti‐thyroid peroxidase antibodies at end of study. </p> </li> <li> <p>Change from baseline in LT<sub>4</sub> replacement dosage at end of study. </p> </li> <li> <p>Economic costs.</p> </li> </ul> </p> <section id="CD010223-sec-0056"> <h6 class="title">Timing of outcome measurement</h6> <p>We considered outcomes measured up to three months (short term), from three to six months (medium term) and after six months (long term). </p> </section> <section id="CD010223-sec-0057"> <h6 class="title">Summary of findings table</h6> <p>We established a '<a href="./full#CD010223-tbl-0001">summary of findings Table for the main comparison</a>' table using the following outcomes listed according to priority: </p> <p> <ul id="CD010223-list-0005"> <li> <p>Change from baseline in HRQoL.</p> </li> <li> <p>Change from baseline in assessment of symptoms such as mood, fatigue and muscle weakness.</p> </li> <li> <p>Proportion of participants reporting an adverse event.</p> </li> <li> <p>Change from baseline in serum levels of anti‐thyroid peroxidase antibodies.</p> </li> <li> <p>Change from baseline in LT<sub>4</sub> replacement dosage. </p> </li> <li> <p>Economic costs.</p> </li> </ul> </p> </section> </section> </section> </section> <section id="CD010223-sec-0058"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010223-sec-0059"> <h4 class="title">Electronic searches</h4> <p>We used the following sources from inception to 2 October 2012 for identification of trials: </p> <p> <ul id="CD010223-list-0006"> <li> <p><i>The Cochrane Library.</i> </p> </li> <li> <p>MEDLINE.</p> </li> <li> <p>EMBASE.</p> </li> <li> <p>Web of Science.</p> </li> </ul> </p> <p>We (EvZ) also searched databases of ongoing trials (ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov/</a>)), the Current Controlled Trials metaRegister (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com/</a>) and the EU Clinical Trials register (<a href="http://www.clinicaltrialsregister.eu/" target="_blank">www.clinicaltrialsregister.eu/</a>) on 5 November 2012. We have provided information including trial identifiers for recognised studies in the '<a href="./references#CD010223-sec-0177" title="">Characteristics of ongoing studies</a>' table and the appendix 'Matrix of study endpoints (protocol/trial documents)'. For every included study, we tried to find its protocol in databases of ongoing trials, in publications of study designs or in both. </p> <p>For detailed search strategies, please see <a href="./appendices#CD010223-sec-0156">Appendix 1</a> (searches were not more than six months old at the time the final review draft was checked into the Cochrane Information and Management System for editorial approval). We used PubMed's 'My NCBI' (National Centre for Biotechnology Information) email alert service to identify newly published studies using a basic search strategy (see <a href="./appendices#CD010223-sec-0156">Appendix 1</a>). </p> <p>For future updates, if additional key words of relevance are detected during any of the electronic or other searches, we will modify the electronic search strategies to incorporate these terms. We have included studies published in any language. </p> </section> <section id="CD010223-sec-0060"> <h4 class="title">Searching other resources</h4> <p>We (EvZ) tried to identify other potentially eligible trials or ancillary publications by searching the reference lists of retrieved included trials, (systematic) reviews, meta‐analyses and health technology assessment reports. </p> </section> </section> <section id="CD010223-sec-0061"> <h3 class="title" id="CD010223-sec-0061">Data collection and analysis</h3> <section id="CD010223-sec-0062"> <h4 class="title">Selection of studies</h4> <p>To determine the studies to be assessed further, two review authors (AYA, EvZ) independently scanned the abstract, title or both sections of every record retrieved. We investigated all potentially relevant articles as full text. Where differences in opinion existed, they were resolved by a third party. We present an adapted PRISMA (Preferred Reporting Items for Systematic reviews and Meta‐Analyses) flow chart of study selection (<a href="#CD010223-fig-0001">Figure 1</a>) (<a href="./references#CD010223-bbs2-0039" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , GøtzschePC , IoannidisJPA , et al. The PRISMA statement for reporting systematic and meta‐analyses of studies that evaluate interventions: explanation and elaboration. PLoS Medicine2009;6(7):1‐28. [DOI: 10.1371/journal.pmed.1000100] ">Liberati 2009</a>). </p> <div class="figure" id="CD010223-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010223-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_n/nCD010223-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010223-sec-0063"> <h4 class="title">Data extraction and management</h4> <p>For studies that fulfilled inclusion criteria, three review authors (AYA, EvZ, ZF) independently abstracted relevant population and intervention characteristics using standard data extraction templates (for details see <a href="./references#CD010223-sec-0174" title="">Characteristics of included studies</a>, <a href="#CD010223-tbl-0003">Table 2</a>; <a href="./appendices#CD010223-sec-0157">Appendix 2</a>; <a href="./appendices#CD010223-sec-0158">Appendix 3</a>; <a href="./appendices#CD010223-sec-0159">Appendix 4</a>; <a href="./appendices#CD010223-sec-0160">Appendix 5</a>; <a href="./appendices#CD010223-sec-0161">Appendix 6</a>; <a href="./appendices#CD010223-sec-0162">Appendix 7</a>; <a href="./appendices#CD010223-sec-0163">Appendix 8</a>; <a href="./appendices#CD010223-sec-0164">Appendix 9</a>) with any disagreements resolved by discussion. </p> <div class="table" id="CD010223-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of study populations</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Characteristic</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>[N] Screened/eligible</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>[N] Randomised</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>[N] Safety</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>[N] ITT</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>[N] Finishing study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>[%] Randomised finishing study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Follow‐up<sup>a</sup> </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Karanikas 2008</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: LT<sub>4</sub> + 200 μg sodium selenite </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: LT<sub>4</sub> + placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>total:</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p><b>Krysiak 2011</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I1: Levothyroxine sodium</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I2: Selenomethionine 200 μg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I3: Levothyroxine sodium<br/> + selenomethionine 200 μg </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C1: Placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>total:</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>165</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>165</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Negro 2007</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: 200 μg selenomethionine</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2227</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>from 12 weeks' gestation to12 months' post partum</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: Placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>total:</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>169</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Turker 2006</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: LT<sub>4</sub> + 200 μg + L‐selenomethionine </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: LT<sub>4</sub> + placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>total:</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b><i>Total</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All interventions</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>279</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All controls</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>184</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All interventions and controls</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>463</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Duration of intervention and/or follow‐up under randomised conditions until end of study. </p> <p>‐ = not reported.</p> <p>ITT: intention‐to‐treat; N/A: not applicable.</p> </div> </div> <p>We sent an email request to the contact persons of included studies for further questions regarding the trials. The results of this survey are published in <a href="./appendices#CD010223-sec-0165">Appendix 10</a>. Thereafter, we sought relevant missing information on the trial from the primary author(s) of the article. </p> <section id="CD010223-sec-0064"> <h5 class="title">Dealing with duplicate publications and companion papers</h5> <p>In the case of duplicate publications and companion papers of a primary study, we sought to maximise yield of information by simultaneous evaluation of all available data. </p> </section> </section> <section id="CD010223-sec-0065"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Three review authors (AYA, EvZ, ZF) assessed each trial independently. We resolved possible disagreements by consensus. </p> <p>We assessed risk of bias using The Cochrane Collaboration's tool (<a href="./references#CD010223-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>; <a href="./references#CD010223-bbs2-0030" title="HigginsJP , AltmanDG , GotzschePC , JuniP , MoherD , OxmanAD , et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ2011;343:d5928. ">Higgins 2011a</a>). We used the following bias criteria. </p> <p> <ul id="CD010223-list-0007"> <li> <p>Random sequence generation (selection bias).</p> </li> <li> <p>Allocation concealment (selection bias).</p> </li> <li> <p>Blinding (performance bias and detection bias), separated for blinding of participants and personnel and blinding of outcome assessment. </p> </li> <li> <p>Incomplete outcome data (attrition bias).</p> </li> <li> <p>Selective reporting (reporting bias) ‐ see <a href="./appendices#CD010223-sec-0160">Appendix 5</a>. </p> </li> <li> <p>Other bias.</p> </li> </ul> </p> <p>We judged risk of bias criteria as 'low risk', 'high risk' or 'unclear risk' and evaluated individual bias items as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010223-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We included a 'Risk of bias' graph figure (<a href="#CD010223-fig-0002">Figure 2</a>) and a 'Risk of bias' summary figure (<a href="#CD010223-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD010223-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010223-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_n/nCD010223-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010223-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010223-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_n/nCD010223-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>We assessed the impact of individual bias domains on study results at endpoint and study levels. </p> <p>For blinding of participants and personnel (performance bias), detection bias (blinding of outcome assessors) and attrition bias (incomplete outcome data), we evaluated risk of bias separately for subjective and objective outcomes. </p> <p>We defined the following endpoints as subjective outcomes:</p> <p> <ul id="CD010223-list-0008"> <li> <p>Change from baseline in HRQoL.</p> </li> <li> <p>Change from baseline in assessment of mood and fatigue.</p> </li> <li> <p>Proportion of participants reporting an adverse event.</p> </li> </ul> </p> <p>We defined the following outcomes as objective outcomes:</p> <p> <ul id="CD010223-list-0009"> <li> <p>Change from baseline in serum levels of anti‐thyroid peroxidase antibodies.</p> </li> <li> <p>Change from baseline in LT<sub>4</sub> replacement dosage. </p> </li> <li> <p>Change from baseline in muscle weakness.</p> </li> <li> <p>Economic costs.</p> </li> </ul> </p> </section> <section id="CD010223-sec-0066"> <h4 class="title">Measures of treatment effect</h4> <p>We presented continuous outcomes on the original scale as reported in each individual study. Dichotomous outcomes were presented as risk ratios (RRs) and if significant were converted to the number needed to treat for an additional beneficial outcome (NNTB). </p> <p>All outcomes data were reported with their associated 95% confidence intervals (CIs) and were analysed using a random‐effects model in RevMan (<a href="./references#CD010223-bbs2-0046" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">RevMan 2011</a>) and the Mantel Haenzel test for dichotomous outcome data and invariance analysis for continuous outcome data, unless stated otherwise. </p> </section> <section id="CD010223-sec-0067"> <h4 class="title">Unit of analysis issues</h4> <section id="CD010223-sec-0068"> <h5 class="title">Cluster‐randomised trials</h5> <p>For future updates, if cluster randomised trials (i.e. groups of individuals randomly assigned to intervention or control) are identified from searches, these will be checked for unit of analysis errors based on the advice provided in Section 16.3.4 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010223-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). If studies are analysed that do not account for clustering, standard errors will be inflated for the effect of clustering and CIs and P values re‐calculated. If this is not possible, study results will be presented only as point estimates without P values or CIs. </p> </section> <section id="CD010223-sec-0069"> <h5 class="title">Cross‐over trials</h5> <p>Unit of analysis issues can arise in studies in which participants have been randomly assigned to multiple treatments in multiple periods, or where an inadequate wash‐out period has been reported. We assessed the carry‐over and period effects in one study descriptively and analysed these data based on the advice provided in Section 16.4.4 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010223-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD010223-sec-0070"> <h5 class="title">Studies with multiple treatment groups</h5> <p>Studies that are reported with multiple treatment groups have the potential for participant data to contribute to multiple comparisons. We assessed the comparisons for clinical importance and included only those that address the primary outcomes. In cases where all comparisons are of equal clinical value, we split the 'shared' group equally into the number of comparisons made, as discussed in Section 16.5.4 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010223-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> </section> <section id="CD010223-sec-0071"> <h4 class="title">Dealing with missing data</h4> <p>If data were missing from trials that were less than 10 years old, we tried wherever possible to contact the investigators or sponsors of these studies. We tried to re‐analyse data according to the intention‐to‐treat (ITT) principle whenever possible. For dichotomous outcomes, if authors had conducted a per‐protocol analysis, we carried out an ITT analysis by imputation setting the missing data to reflect treatment failure, checking the degree of imbalance of the drop‐out between arms to determine the potential impact of bias (Section 16.2.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010223-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>)). For continuous outcomes, a per‐protocol analysis was carried out in place of an ITT analysis. </p> <p>In circumstances where partial data were presented in the primary research, we have calculated the change from baseline and associated standard deviation with an assumed correlation coefficient between baseline and follow‐up of 0.75, consistent with the nature of biomarker outcomes. In each case the calculation was repeated with an assumed weaker correlation of 0.5. </p> </section> <section id="CD010223-sec-0072"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical heterogeneity by examining the characteristics of studies, the similarity between types of participants and the interventions. We planned to report heterogeneity as important if it was substantial (I<sup>2</sup> between 50% and 90%, <a href="./references#CD010223-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>); if the I<sup>2</sup> statistic was greater than 90%, the meta‐analysis would not have been carried out. However, if heterogeneity could be explained by clinical reasoning and a coherent argument could be made for combining the studies, we planned to enter these into a meta‐analysis. In cases where the heterogeneity could not be adequately explained, we planned not to pool the data. </p> </section> <section id="CD010223-sec-0073"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates, assessments of reporting bias will follow the recommendations on testing for funnel plot asymmetry (<a href="./references#CD010223-bbs2-0025" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. [PUBMED: PMID: 9310563] ">Egger 1997</a>), as described in Section 10.4.3.1 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010223-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). These assessments will be performed for primary and secondary outcomes for meta‐analysis when a minimum number of studies are included to allow a reasonable estimate of the effect of intervention (nominally nine studies). Funnel plots will be presented only when some evidence of asymmetry is seen in the plots. Possible sources of asymmetry will be explored through an additional sensitivity analysis. </p> </section> <section id="CD010223-sec-0074"> <h4 class="title">Data synthesis</h4> <p>In future updates, if adequate studies are identified from the searches, these data will be analysed in RevMan (<a href="./references#CD010223-bbs2-0046" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">RevMan 2011</a>) and reported in accordance with the advice in Chapter 9 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010223-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). A random‐effects meta‐analysis will be carried out in studies that investigate similar interventions and report data that exhibited not more than moderate heterogeneity. </p> </section> <section id="CD010223-sec-0075"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If an adequate number of studies had been reported, we planned to carry out subgroup analyses of the following primary outcomes: </p> <p> <ul id="CD010223-list-0010"> <li> <p>Age.</p> </li> <li> <p>Selenium status at baseline.</p> </li> <li> <p>Type of selenium (selenomethionine or sodium selenite).</p> </li> <li> <p>Selenium dose (100 or 200 µg/day).</p> </li> <li> <p>Different baseline anti‐TPOAb.</p> </li> <li> <p>Gender.</p> </li> </ul> </p> </section> <section id="CD010223-sec-0076"> <h4 class="title">Sensitivity analysis</h4> <p>In future updates, if adequate numbers of studies are identified, we will perform sensitivity analyses to explore the influence of the following factors on effect sizes: </p> <p> <ul id="CD010223-list-0011"> <li> <p>Restricting the analysis to published studies.</p> </li> <li> <p>Restricting the analysis while taking into account risk of bias, as specified earlier.</p> </li> <li> <p>Restricting the analysis to very long or large studies to establish how much they dominate the results. </p> </li> <li> <p>Restricting the analysis to studies using the following filters: diagnostic criteria, language of publication, source of funding (industry vs other) and country. </p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010223-sec-0077" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010223-sec-0077"></div> <section id="CD010223-sec-0078"> <h3 class="title">Description of studies</h3> <p>For a detailed description of studies, see <a href="./references#CD010223-sec-0174" title="">Characteristics of included studies</a>, <a href="./references#CD010223-sec-0175" title="">Characteristics of excluded studies,</a><a href="./references#CD010223-sec-0176" title="">Characteristics of studies awaiting classification</a> and <a href="./references#CD010223-sec-0177" title="">Characteristics of ongoing studies</a>. </p> <section id="CD010223-sec-0079"> <h4 class="title">Results of the search</h4> <p>The initial search identified 110 records; from these, nine full text papers were identified for further examination. We excluded the other studies on the basis of their titles or abstracts because they did not meet the inclusion criteria, they were not relevant to the question under study or they presented a duplicate report (see <a href="#CD010223-fig-0001">Figure 1</a> for the amended PRISMA [preferred reporting items for systematic reviews and meta‐analyses] flow chart). After the full text of the selected publications was screened, four studies (four publications) were deemed to meet the inclusion criteria. All studies were published in English. We contacted all authors of included studies and received a reply from two (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>). We sought additional information from the authors of seven studies (<a href="./references#CD010223-bbs2-0007" title="DuntasLH , MantzouE , KoutrasDA . Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. European Journal of Endocrinology / European Federation of Endocrine Societies2003;148(4):389‐93. [PUBMED: PMID: 12656658] ">Duntas 2003</a>; <a href="./references#CD010223-bbs2-0008" title="GärtnerR , GasnierBC , DietrichJW , KrebsB , AngstwurmMW . Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. Journal of Clinical Endocrinology and Metabolism2002;87(4):1687‐91. [PUBMED: PMID: 11932302] ">Gärtner 2002</a>; <a href="./references#CD010223-bbs2-0009" title="GärtnerR , GasnierBC . Selenium in the treatment of autoimmune thyroiditis. Biofactors2003;19(3‐4):165‐70. [PUBMED: PMID: 14757967] ">Gärtner 2003</a>; <a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0010" title="NacamulliD , MianC , PetriccaD , LazzarottoF , BarolloS , PozzaD , et al. Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clinical Endocrinology (Oxf)2010;73(4):535‐9. [PUBMED: PMID: 20039895] ">Nacamulli 2010</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>). Six authors responded to these requests and provided further data (see <a href="./appendices#CD010223-sec-0165">Appendix 10</a>). </p> <p>After the search had been completed, an additional study (<a href="./references#CD010223-bbs2-0011" title="KrysiakR , OkopienB . Haemostatic effects of levothyroxine and selenomethionine in euthyroid patients with Hashimoto's thyroiditis. Thrombosis and Haemostasis2012;108(5):973‐80. [PUBMED: PMID: 22918596] ">Krysiak 2012</a>) was found, which is located in <a href="./references#CD010223-sec-0176" title="">Characteristics of studies awaiting classification</a>. This study has not been added to <a href="#CD010223-fig-0001">Figure 1</a> but will be considered in the next update of this review. </p> </section> <section id="CD010223-sec-0080"> <h4 class="title">Included studies</h4> <p>A detailed description of the characteristics of included studies is presented elsewhere (see <a href="./references#CD010223-sec-0174" title="">Characteristics of included studies</a> and appendices). A succinct overview follows. </p> <section id="CD010223-sec-0081"> <h5 class="title">Comparisons</h5> <p>The four studies described different comparisons (see <a href="./appendices#CD010223-sec-0157">Appendix 2</a>): </p> <p> <ul id="CD010223-list-0012"> <li> <p>In <a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a> the treatment arm received levothyroxine (LT<sub>4</sub>) combined with 200 μg sodium selenite, while the control arm received LT<sub>4</sub> with a placebo. </p> </li> <li> <p>The study of <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a> included four arms; one treatment arm with LT<sub>4</sub>, one with selenomethionine 200 μg, one with LT<sub>4</sub> and selenomethionine 200 μg and one placebo arm. </p> </li> <li> <p>In <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a> selenomethionine 200 μg was compared with placebo. </p> </li> <li> <p>Participants in the treatment arm in the study of <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a> received LT<sub>4</sub> combined with selenomethionine 200 μg, while the control arm received LT<sub>4</sub> plus placebo. </p> </li> </ul> </p> </section> <section id="CD010223-sec-0082"> <h5 class="title">Overview of study populations</h5> <p>A total of 463 participants were included in the four trials; 279 participants were randomised to <i>intervention</i> and 184 to <i>control</i> groups. </p> <p>An unclear number of participants finished the study in the <i>intervention</i> and <i>control</i> groups because of the fact that only means were reported in two studies, and it was unclear whether all participants were entered into the analysis. </p> <p>Individual sample size ranged from 36 to 170. For further details, see <a href="#CD010223-tbl-0003">Table 2</a>. </p> </section> <section id="CD010223-sec-0083"> <h5 class="title">Study design</h5> <p>Studies were randomised controlled trials. All four trials adopted a parallel‐group superiority design, and all studies used a placebo control (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>). </p> <p>Two trials were multi‐centred (<a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>;<a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>), both with two centres. </p> <p>In terms of blinding, one study was double‐blinded for participants and personnel (<a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>), no studies were single‐blinded for participants and in one study, blinding was not defined (<a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>). Outcome assessors were blinded in one study (<a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>). Investigators in two studies stated that the study was blinded, but no further details were given about the specific measures used to blind personnel and participants from knowledge of which intervention a participant was receiving (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>;<a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>). </p> <p>Studies were performed between the years 2006 and 2011.</p> <p>The duration of interventions ranged from three to 18 months, with a mean study period of 7.5 months. </p> <p>No study included a follow‐up period.</p> <p>None of the studies had a run‐in period.</p> <p>None of the studies was terminated before regular end.</p> </section> <section id="CD010223-sec-0084"> <h5 class="title">Settings</h5> <p>All studies were conducted in an outpatient setting in a hospital.</p> </section> <section id="CD010223-sec-0085"> <h5 class="title">Participants</h5> <p>The participating population consisted of the following: women with auto‐immune thyroiditis (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>;<a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>), euthyroid women who had recently been diagnosed with Hashimoto's thyroiditis (<a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>) and pregnant women with positive anti‐TPO antibodies (<a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>). </p> <p>Four trials included participants from economically developed countries.</p> <p>Ethnic groups were distributed as follows: Caucasian (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>); the other two studies did not provide details on ethnicity. </p> <p>The duration of auto‐immune thyroiditis was not reported in any trial.</p> <p>Only women were included in all studies (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>). </p> <p>The mean age of participants in the trials ranged from 28 to 47 years.</p> <p>One trial reported co‐morbidities of participants (<a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>), one trial co‐interventions in participants (<a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>) and no trials co‐medications used by participants. </p> <p>Criteria for entry into the individual studies are outlined in the <a href="./references#CD010223-sec-0174" title="">Characteristics of included studies</a>. </p> </section> <section id="CD010223-sec-0086"> <h5 class="title">Diagnosis</h5> <p>Participants were diagnosed with auto‐immune thyroiditis in all four studies (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>). </p> <p>None of the studies confirmed the diagnosis of auto‐immune thyroiditis against standard diagnostic criteria. All four studies did not refer to standard diagnostic criteria but instead relied on third party diagnosis of auto‐immune thyroiditis before study enrolment. </p> </section> <section id="CD010223-sec-0087"> <h5 class="title">Interventions</h5> <p>One study reported treatment before the start of the trial (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>) consisting of LT<sub>4</sub>. </p> <p>None of the studies had a titration period.</p> <p>Intervention was applied by the oral route once a day.</p> <p>The daily dosage of sodium selenite or selenomethionine was 200 μg.</p> <p>All studies used a matching placebo as the control intervention (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>). </p> <p>The duration of treatment ranged from three to 18 months, with a mean treatment duration of 7.5 months. </p> </section> <section id="CD010223-sec-0088"> <h5 class="title">Outcomes</h5> <p>All studies explicitly stated a primary endpoint in the publication (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>); none of the studies provided secondary endpoints. </p> <p><i>Reporting of endpoints</i> </p> <p>One study assessed subjective well‐being (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>). </p> <p>Anti‐TPO antibodies were measured from baseline in all studies (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>). </p> <p>Two studies reported on adverse events (<a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>). </p> <p>No studies investigated HRQoL, change from baseline in LT<sub>4</sub> replacement dosage at end of study or cost of treatment. </p> <p>For a summary of all outcomes assessed in each study, see <a href="./appendices#CD010223-sec-0162">Appendix 7</a>. </p> <p>Three studies provided a definition of endpoint measurement (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>) for the following outcomes: subjective well‐being, anti‐TPO antibody measurement and LT<sub>4</sub> replacement. </p> </section> </section> <section id="CD010223-sec-0089"> <h4 class="title">Excluded studies</h4> <p>Six studies were excluded after careful evaluation of the full text of the publication (<a href="./references#CD010223-bbs2-0005" title="BalázsC . The effect of selenium therapy on autoimmune thyroiditis [A szelénkezelés hatásaaz autoimmun thyreoiditisre (Hungarian)]. Orvosi Hetilap2008;149(26):1227‐32. [PUBMED: PMID: 18565817] ">Balázs 2008</a>; <a href="./references#CD010223-bbs2-0006" title="ContempréB , DualeNL , DumontJE , NgoB , DiplockAT , VanderpasJ . Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clinical Endocrinology1992;36(6):579‐83. [PUBMED: PMID: 1424183] ">Contempré 1992</a>; <a href="./references#CD010223-bbs2-0007" title="DuntasLH , MantzouE , KoutrasDA . Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. European Journal of Endocrinology / European Federation of Endocrine Societies2003;148(4):389‐93. [PUBMED: PMID: 12656658] ">Duntas 2003</a>; <a href="./references#CD010223-bbs2-0008" title="GärtnerR , GasnierBC , DietrichJW , KrebsB , AngstwurmMW . Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. Journal of Clinical Endocrinology and Metabolism2002;87(4):1687‐91. [PUBMED: PMID: 11932302] ">Gärtner 2002</a>; <a href="./references#CD010223-bbs2-0009" title="GärtnerR , GasnierBC . Selenium in the treatment of autoimmune thyroiditis. Biofactors2003;19(3‐4):165‐70. [PUBMED: PMID: 14757967] ">Gärtner 2003</a>; <a href="./references#CD010223-bbs2-0010" title="NacamulliD , MianC , PetriccaD , LazzarottoF , BarolloS , PozzaD , et al. Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clinical Endocrinology (Oxf)2010;73(4):535‐9. [PUBMED: PMID: 20039895] ">Nacamulli 2010</a>) (see <a href="#CD010223-fig-0001">Figure 1</a>). </p> <p>The main reason for exclusion was that these appeared to be controlled clinical trials. Four studies were reported to be randomised, but after e‐mail contact with the investigators, these were classified as quasi‐randomised. For further details, see <a href="./references#CD010223-sec-0175" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD010223-sec-0090"> <h3 class="title">Risk of bias in included studies</h3> <p>For details on risk of bias of included studies, see <a href="./references#CD010223-sec-0174" title="">Characteristics of included studies</a>. </p> <p>For an overview of review authors' judgments about each risk of bias item for individual studies and across all studies, see <a href="#CD010223-fig-0002">Figure 2</a> and <a href="#CD010223-fig-0003">Figure 3</a>. </p> <p>We investigated performance bias, detection bias and attrition bias separately for objective and subjective outcome measures. </p> <p>We defined 'objective outcome' measures as follows: change from baseline in serum levels of anti‐thyroid peroxidase antibodies, change from baseline in LT<sub>4</sub> replacement dosage, change from baseline in muscle weakness and economic costs. </p> <p>We defined 'subjective outcome' measures as follows: change from baseline in HRQoL, change from baseline in assessment of mood and fatigue and proportions of participants reporting an adverse event. </p> <section id="CD010223-sec-0091"> <h4 class="title">Allocation</h4> <section id="CD010223-sec-0092"> <h5 class="title">Sequence generation</h5> <p>In two studies (<a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>), the method used to generate the allocation sequence was described in sufficient detail; therefore, this domain was judged as low risk of bias for these studies. However, in the two remaining studies (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>), sequence generation was based on prognostic factors such as serum level of anti‐TPO antibodies and age, and there was no indication that stratified randomisation had been used; accordingly, the domain was judged as at high risk of bias. </p> </section> <section id="CD010223-sec-0093"> <h5 class="title">Allocation concealment</h5> <p>Reports of two studies (<a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>) provided sufficient detail and reassurance that participants and investigators enrolling those participants could not foresee the upcoming assignment. For the other two studies (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>), the method used to conceal the allocation sequence was not reported; thus, they received a judgment of unclear risk of bias for this domain. </p> </section> </section> <section id="CD010223-sec-0094"> <h4 class="title">Blinding</h4> <p>Three studies explicitly stated that blinding of participants and personnel was undertaken but did not provide sufficient information about blinding procedures (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>); the remaining study did not report any blinding (<a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>). </p> <p>Most of the objective outcomes were based on blood tests; however, this is unlikely to have introduced bias into the outcome assessment. We judged this for three studies as having low risk of bias (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006)</a>. One study included thyroid ultrasound as well as an outcome; this can be potentially confounded by prior knowledge of treatment intervention (<a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>). Therefore we judged the domain for detection bias here as high risk of bias. Only one study assessed a subjective outcome (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>), but the method used to blind the assessment of subjective outcomes by participants was not described; therefore we judged this as having unclear risk of bias. </p> </section> <section id="CD010223-sec-0095"> <h4 class="title">Incomplete outcome data</h4> <p>Only one study described a subjective outcome (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>); the other studies included only objective outcomes (<a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>). </p> <p>Numbers of study withdrawals were described in two studies that had losses to follow‐up (<a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>). </p> <p>Analysis was reported as ITT in one study for the subjective outcome but not for the objective outcomes (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>). No ITT analysis was undertaken in the trials by <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a> and <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>. </p> <p>Two studies did not report losses to follow‐up and reported only means of the outcomes without numbers of participants (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>). </p> </section> <section id="CD010223-sec-0096"> <h4 class="title">Selective reporting</h4> <p>The protocol for three of the studies was not available, but the prespecified outcomes and those mentioned in the methods section appeared to have been reported; therefore we judged this domain in these studies as having low risk of bias (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>). However, the free thyroxine (FT<sub>4</sub>) values were incompletely reported in <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>, and we judged this as having unclear risk of bias (see also <a href="./appendices#CD010223-sec-0160">Appendix 5</a>). </p> </section> <section id="CD010223-sec-0097"> <h4 class="title">Other potential sources of bias</h4> <p>All four studies appeared to be free of other forms of bias, and we judged this domain as having low risk of bias. </p> </section> </section> <section id="CD010223-sec-0098"> <h3 class="title" id="CD010223-sec-0098">Effects of interventions</h3> <p>See: <a href="./full#CD010223-tbl-0001"><b>Summary of findings for the main comparison</b> Selenium (+LT4) compared to placebo (+LT4) for participants with Hashimoto's thyroiditis</a> </p> <section id="CD010223-sec-0099"> <h4 class="title">Baseline characteristics</h4> <p>For details of baseline characteristics, see <a href="./appendices#CD010223-sec-0158">Appendix 3</a> and <a href="./appendices#CD010223-sec-0159">Appendix 4</a>. </p> </section> <section id="CD010223-sec-0100"> <h4 class="title">(1) Sodium selenite 200 μg plus titrated LT<sub>4</sub> versus placebo plus titrated LT<sub>4</sub> </h4> <p>One study judged as having high risk of bias provided data for this comparison (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>). </p> <section id="CD010223-sec-0101"> <h5 class="title">Primary outcomes</h5> <section id="CD010223-sec-0102"> <h6 class="title">Change from baseline in HRQoL assessed using any validated quality‐of‐life instrument at end of study </h6> <p>This outcome was not assessed.</p> </section> <section id="CD010223-sec-0103"> <h6 class="title">Change from baseline in symptoms such as mood, fatigue and muscle weakness assessed using any validated instrument at end of study </h6> <p>Subjective well‐being (assessed with short form health survey) was improved in 14/18 participants receiving sodium selenite compared with 3/18 in the placebo group (RR 4.67, 95% CI 1.61 to 13.50; P = 0.004; number needed to treat (NNT) = 2 (95% CI 2 to 3). </p> </section> <section id="CD010223-sec-0104"> <h6 class="title">Proportions of participants reporting an adverse event throughout the study period</h6> <p>This outcome was not assessed.</p> </section> </section> <section id="CD010223-sec-0105"> <h5 class="title">Secondary outcomes</h5> <section id="CD010223-sec-0106"> <h6 class="title">Change from baseline in serum levels of anti‐thyroid peroxidase (TPO) antibodies at end of study </h6> <p>The anti‐TPO antibodies changed from 524 ± 452 IU/mL at baseline to 505 ± 464 IU/mL for the sodium selenite group and from 521 ± 349 IU/mL to 527 ± 354 IU/mL for the placebo group. The mean difference (MD) was estimated to be ‐25 (95% CI ‐181 to 131; P = 0.75; 36 participants). </p> </section> <section id="CD010223-sec-0107"> <h6 class="title">Change from baseline in LT<sub>4</sub> replacement dosage at end of study </h6> <p>This outcome was not assessed.</p> </section> <section id="CD010223-sec-0108"> <h6 class="title">Economic costs</h6> <p>This outcome was not assessed.</p> </section> </section> </section> <section id="CD010223-sec-0109"> <h4 class="title">(2) Selenomethionine 200 μg versus placebo</h4> <p>Two studies compared the efficacy of selenomethionine versus placebo (<a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>). </p> <section id="CD010223-sec-0110"> <h5 class="title">Primary outcomes</h5> <section id="CD010223-sec-0111"> <h6 class="title">Change from baseline in HRQoL assessed using any validated quality‐of‐life instrument at end of study </h6> <p>This outcome was not assessed.</p> </section> <section id="CD010223-sec-0112"> <h6 class="title">Change from baseline in symptoms such as mood, fatigue and muscle weakness assessed using any validated instrument at end of study </h6> <p>This outcome was not assessed.</p> </section> <section id="CD010223-sec-0113"> <h6 class="title">Proportions of participants reporting an adverse event throughout the study period</h6> <p>No adverse events were reported in either group (<a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>). This outcome was no assessed in the other study (<a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>). </p> </section> </section> <section id="CD010223-sec-0114"> <h5 class="title">Secondary outcomes</h5> <section id="CD010223-sec-0115"> <h6 class="title">Change from baseline in serum levels of anti‐TPO antibodies at end of study</h6> <p>There was a clearly discernible end of study reduction in anti‐TPO antibody values, as compared to baseline, for participants in the selenomethionine group in both studies. The MDs were estimated as ‐917 IU/mL (<a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>) and ‐345 IU/mL (<a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>), both P &lt; 0.001. Pooling of the studies was not feasible due to marked clinical heterogeneity, which was attributable to variability in the characteristics of the  women included in the studies  i.e. recently diagnosed euthyroid women not undergoing treatment with high baseline TPO antibodies (<a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>), versus pregnant women diagnosed with Hashimoto’s and low baseline TPO antibodies (<a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>). These results are presented in a forest plot, partitioned into two subgroups (I<sup>2</sup> = 99%; P &lt; 0.0001, see <a href="./references#CD010223-fig-0004" title="">Analysis 1.1</a>).This analysis demonstrates a clear reduction in serum levels of anti‐TPO antibodies between selenomethionine (200 μg) and placebo (see <a href="./references#CD010223-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD010223-sec-0116"> <h6 class="title">Change from baseline in LT<sub>4</sub> replacement dosage at end of study </h6> <p>This outcome was not assessed.</p> </section> <section id="CD010223-sec-0117"> <h6 class="title">Economic costs</h6> <p>This outcome was not assessed.</p> </section> </section> </section> <section id="CD010223-sec-0118"> <h4 class="title">(3) Selenomethionine 200 μg plus titrated LT<sub>4</sub> versus placebo </h4> <p>The study evaluating comparison (2) also compared the efficacy of selenomethionine plus titrated LT<sub>4</sub> versus placebo (<a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>). </p> <section id="CD010223-sec-0119"> <h5 class="title">Primary outcomes</h5> <section id="CD010223-sec-0120"> <h6 class="title">Change from baseline in HRQoL assessed using any validated quality‐of‐life instrument at end of study </h6> <p>This outcome was not assessed.</p> </section> <section id="CD010223-sec-0121"> <h6 class="title">Change from baseline in symptoms such as mood, fatigue and muscle weakness assessed using any validated instrument at end of study </h6> <p>This outcome was not assessed.</p> </section> <section id="CD010223-sec-0122"> <h6 class="title">Proportions of participants reporting an adverse event throughout the study period</h6> <p>In the active treatment group, 1/43 reported an adverse event versus 0/42 in the placebo group (RR 2.93, 95% CI 0.12 to 70.00). </p> </section> </section> <section id="CD010223-sec-0123"> <h5 class="title">Secondary outcomes</h5> <section id="CD010223-sec-0124"> <h6 class="title">Change from baseline in serum levels of anti‐TPO antibodies at end of study</h6> <p>Anti‐TPO antibodies changed from 1810 ± 452 U/mL at baseline to 463 ± 104 U/mL at end of study in the group treated with selenomethionine plus titrated LT<sub>4</sub> and from 1723 ± 410 IU/L to 1884 ± 346 U/mL in the placebo group. The MD was estimated to be ‐1508 U/mL (95% CI ‐1672 to ‐1345); P &lt; 0.001; 86 participants). This demonstrated a clear reduction in serum levels of anti‐TPO antibodies between selenomethionine (200 μg) plus titrated LT<sub>4</sub> and placebo. </p> </section> <section id="CD010223-sec-0125"> <h6 class="title">Change from baseline in LT<sub>4</sub> replacement dosage at end of study </h6> <p>This outcome was not assessed.</p> </section> <section id="CD010223-sec-0126"> <h6 class="title">Economic costs</h6> <p>This outcome was not assessed.</p> </section> </section> </section> <section id="CD010223-sec-0127"> <h4 class="title">(4) L‐selenomethionine 200 μg plus titrated LT<sub>4</sub> versus placebo plus titrated LT<sub>4</sub> </h4> <p>This comparison was examined by one study at high risk of bias (<a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>). </p> <section id="CD010223-sec-0128"> <h5 class="title">Primary outcomes</h5> <section id="CD010223-sec-0129"> <h6 class="title">Change from baseline in HRQoL assessed using any validated quality‐of‐life instrument at end of study </h6> <p>This outcome was not assessed.</p> </section> <section id="CD010223-sec-0130"> <h6 class="title">Change from baseline in symptoms such as mood, fatigue and muscle weakness assessed using any validated instrument at end of study </h6> <p>This outcome was not assessed.</p> </section> <section id="CD010223-sec-0131"> <h6 class="title">Proportions of participants reporting an adverse event throughout the study period</h6> <p>In the selenomethionine group, 1/48 reported an adverse event (gastric discomfort) versus 0/40 in the placebo group (RR 2.63, 95% CI 0.11 to 62.95). </p> </section> </section> <section id="CD010223-sec-0132"> <h5 class="title">Secondary outcomes</h5> <section id="CD010223-sec-0133"> <h6 class="title">Change from baseline in serum levels of anti‐TPO antibodies at end of study</h6> <p>Anti‐TPO antibody levels decreased from 804 ± 484 IU/L to 572 ± 517 IU/mL in the selenomethionine group and from 770 ± 406 IU/mL to 773 ± 373 IU/mL in the placebo group. The MD was estimated to be ‐235 IU/mL (95% CI ‐374 to ‐95; P = 0.001; 88 participants); this demonstrated a reduction in serum levels of anti‐TPO antibodies between L‐selenomethionine (200 μg) plus titrated LT<sub>4</sub> and placebo plus titrated LT<sub>4</sub>. </p> </section> <section id="CD010223-sec-0134"> <h6 class="title">Change from baseline in LT<sub>4</sub> replacement dosage at end of study </h6> <p>This outcome was not assessed.</p> </section> <section id="CD010223-sec-0135"> <h6 class="title">Economic costs</h6> <p>This outcome was not assessed.</p> </section> </section> </section> <section id="CD010223-sec-0136"> <h4 class="title">Subgroup analyses</h4> <p>We did not perform subgroup analyses because the number of studies was insufficient to allow estimation of effects in various subgroups. </p> </section> <section id="CD010223-sec-0137"> <h4 class="title">Sensitivity analyses</h4> <p>To assess the impact of estimating the change from baseline correlation as 0.75, we changed this to 0.5 and noted no changes in study findings. </p> </section> <section id="CD010223-sec-0138"> <h4 class="title">Assessment of reporting biases</h4> <p>Only one study was identified for each comparison; therefore, we were not able to assess reporting bias. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010223-sec-0139" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010223-sec-0139"></div> <section id="CD010223-sec-0140"> <h3 class="title" id="CD010223-sec-0140">Summary of main results</h3> <p>Four studies at unclear to high risk of bias comprising 463 participants were included. None of the studies addressed our principal primary outcome of 'health‐related quality of life' (HRQoL). Two of our secondary outcomes ('change from baseline in LT<sub>4</sub> replacement dosage at end of study' and 'economic costs') were not assessed either. One study at high risk of bias showed a statistically significant improvement in subjective well‐being with sodium selenite 200 μg plus titrated levothyroxine (LT<sub>4</sub>) compared with placebo plus titrated LT<sub>4</sub> (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>). Selenomethionine 200 μg supplementation was associated with a reduction in the serum levels of anti‐TPO antibodies in three studies (<a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a>; <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>), and although the changes from baseline were significant, they were not considered to be clinically important. One study (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>), which assessed sodium selenite 200 μg plus titrated LT<sub>4</sub>, did not confirm this reduction in serum anti‐thyroid antibodies. Adverse events were reported in two studies, and selenium supplementation did not lead to a statistically significant increase in the number of adverse events when compared with placebo. </p> <p>For further details, see the '<a href="./full#CD010223-tbl-0001">summary of findings Table for the main comparison</a>'.<br/> <br/> Three ongoing studies were identified that may eventually help to fill in some of the gaps in evidence for the efficacy of selenium as a supplement in people with Hashimoto's thyroiditis. </p> </section> <section id="CD010223-sec-0141"> <h3 class="title" id="CD010223-sec-0141">Overall completeness and applicability of evidence</h3> <p>The four studies at unclear to high risk of bias provided very limited data. No clinically relevant conclusions can be drawn on the basis of these four included studies. Hashimoto's thyroiditis has many very debilitating symptoms; therefore, outcomes such as change in HRQoL and improvement in symptoms such as mood, fatigue and muscle weakness are crucial meaningful markers of clinical status. Results of these studies provide incomplete evidence to support or refute the efficacy of selenium in people with Hashimoto's thyroiditis. </p> </section> <section id="CD010223-sec-0142"> <h3 class="title" id="CD010223-sec-0142">Quality of the evidence</h3> <section id="CD010223-sec-0143"> <h4 class="title">Limitations in study design and implementation</h4> <p>Although study design in two of the included studies appeared to have been at best adequate, we judged the sequence generation of the other two studies as having high risk of bias. We were unsuccessful in our attempts to contact the investigators of these last two studies to clarify the methods used to generate the sequence and to conceal the allocation and to obtain details of blinding and losses to follow‐up (see <a href="#CD010223-sec-0090">Risk of bias in included studies</a> section and <a href="./appendices#CD010223-sec-0165">Appendix 10</a> of this review). Furthermore, our key outcomes such as HRQoL and effects on mood, well‐being and fatigue were not addressed in any of the studies, with the exception of well‐being in one study, which was assessed as having high risk of bias. One of our remaining outcomes reflected changes in anti‐TPO antibodies, which, as long as they remain positive, can be considered to a large extent to be not clinically meaningful. </p> </section> <section id="CD010223-sec-0144"> <h4 class="title">Indirectness of the evidence</h4> <p>Participants in the included study in general constituted a clinically representative sample matching the inclusion criteria; therefore, we had no significant concerns about the appropriateness of participants identified in the review. </p> <p>Placebo‐controlled trials are still required to evaluate whether selenium supplementation has any potential beneficial effect on Hashimoto's thyroiditis. The results of these studies provide insufficient evidence to allow any firm conclusions to be drawn to support or refute selenium as additional therapy. </p> <p>Patient‐relevant outcomes are a pre‐requisite for informing evidence‐based clinical decision making, but the importance of patient‐reported outcomes (PROs), specifically those used in evaluating the impact of the intervention on quality of life, appears to have been underestimated by investigators in all of the included studies. </p> </section> <section id="CD010223-sec-0145"> <h4 class="title">Inconsistency of the results</h4> <p>In view of the clinical heterogeneity noted between the studies, and, more specifically, the comparisons evaluated, it was not possible to pool study data; and thus no inferences could be drawn about any possible inconsistency in the results. </p> </section> <section id="CD010223-sec-0146"> <h4 class="title">Imprecision of the results</h4> <p>The primary outcome for this review was assessment of HRQoL, which was not measured in any of the included studies. The results of our secondary outcomes provided varying estimates of anti‐TPO antibody level reduction in each comparison. These effect estimates were generated from single studies that reported large reductions bound by tight confidence intervals. All estimates showed clear reductions, but it should be noted that these were generated from single studies and were subject to increased risk of bias. </p> </section> <section id="CD010223-sec-0147"> <h4 class="title">Publication bias</h4> <p>Although our attempts to identify additional studies yielded three ongoing studies, the possibility of further unpublished research on this topic cannot be excluded. In future updates, and if additional trials are identified for inclusion, we will assess publication bias as specified in the <a href="#CD010223-sec-0073">Assessment of reporting biases</a> section of this review. </p> </section> </section> <section id="CD010223-sec-0148"> <h3 class="title" id="CD010223-sec-0148">Potential biases in the review process</h3> <p>We made every attempt to limit bias in the review process by ensuring a comprehensive search for potentially eligible studies. The authors' independent assessments of eligibility of studies for inclusion in this review minimised the potential for additional bias. </p> </section> <section id="CD010223-sec-0149"> <h3 class="title" id="CD010223-sec-0149">Agreements and disagreements with other studies or reviews</h3> <p>We identified another systematic review that attempted "to summarize available data and provide an evidence‐based recommendation regarding selenium supplementation in the treatment of Hashimoto's thyroiditis" (<a href="./references#CD010223-bbs2-0056" title="ToulisKA , AnastasilakisAD , TzellosTG , GoulisDG , KouvelasD . Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta‐analysis. Thyroid2010;20(10):1163‐73. [PUBMED: PMID: 20883174] ">Toulis 2010</a>). This review included a meta‐analysis of data extracted solely from trials that were 'blinded, randomized, placebo‐controlled in design'. Although this review relied on the consensus process negotiated between investigators and was therefore deemed reasonably transparent, we are in disagreement over the robustness of its methodological approach. Lack of clarity in the process and ultimately its limited reproducibility were illustrated by incomplete reporting of some of the important steps taken in study assessment and handling of missing trial details and data. It appears that no attempts were made to contact any of the investigators in the included studies for clarification of methods used to generate the sequence, allocation concealment or blinding or to retrieve missing data. Furthermore, and quite significantly, no risk of bias assessments of the included studies were undertaken. Of the four studies (<a href="./references#CD010223-bbs2-0007" title="DuntasLH , MantzouE , KoutrasDA . Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. European Journal of Endocrinology / European Federation of Endocrine Societies2003;148(4):389‐93. [PUBMED: PMID: 12656658] ">Duntas 2003</a>; <a href="./references#CD010223-bbs2-0008" title="GärtnerR , GasnierBC , DietrichJW , KrebsB , AngstwurmMW . Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. Journal of Clinical Endocrinology and Metabolism2002;87(4):1687‐91. [PUBMED: PMID: 11932302] ">Gärtner 2002</a>; <a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>) included in the meta‐analysis of this review (<a href="./references#CD010223-bbs2-0056" title="ToulisKA , AnastasilakisAD , TzellosTG , GoulisDG , KouvelasD . Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta‐analysis. Thyroid2010;20(10):1163‐73. [PUBMED: PMID: 20883174] ">Toulis 2010</a>), two were excluded in our review because through email contact, the trial investigators confirmed that these were quasi‐randomised (<a href="./references#CD010223-bbs2-0007" title="DuntasLH , MantzouE , KoutrasDA . Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. European Journal of Endocrinology / European Federation of Endocrine Societies2003;148(4):389‐93. [PUBMED: PMID: 12656658] ">Duntas 2003</a>; <a href="./references#CD010223-bbs2-0008" title="GärtnerR , GasnierBC , DietrichJW , KrebsB , AngstwurmMW . Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. Journal of Clinical Endocrinology and Metabolism2002;87(4):1687‐91. [PUBMED: PMID: 11932302] ">Gärtner 2002</a>). In the other two studies, it was unclear whether participants had been randomly assigned according to strata, or whether the studies were also quasi‐randomised (<a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a>; <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a>), and we were unsuccessful in our attempts to contact study investigators. The other systematic review included two additional studies (<a href="./references#CD010223-bbs2-0009" title="GärtnerR , GasnierBC . Selenium in the treatment of autoimmune thyroiditis. Biofactors2003;19(3‐4):165‐70. [PUBMED: PMID: 14757967] ">Gärtner 2003</a>; <a href="./references#CD010223-bbs2-0040" title="MazokopakisEE , PapadakisJA , PapadomanolakiMG , BatistakisAG , GiannakopoulosTG , ProtopapadakisEE , et al. Effects of 12 months treatment with L‐selenomethionine on serum anti‐TPO Levels in patients with Hashimoto's thyroiditis. Thyroid2007;17(7):609‐12. ">Mazokopakis 2007</a>), which were excluded from our review. We excluded <a href="./references#CD010223-bbs2-0009" title="GärtnerR , GasnierBC . Selenium in the treatment of autoimmune thyroiditis. Biofactors2003;19(3‐4):165‐70. [PUBMED: PMID: 14757967] ">Gärtner 2003</a> on the basis that email communication revealed that this study appeared to be quasi‐randomised, and although the study design was not an exclusion criterion for the systematic review of <a href="./references#CD010223-bbs2-0056" title="ToulisKA , AnastasilakisAD , TzellosTG , GoulisDG , KouvelasD . Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta‐analysis. Thyroid2010;20(10):1163‐73. [PUBMED: PMID: 20883174] ">Toulis 2010</a>, this study was excluded from the meta‐analysis. <a href="./references#CD010223-bbs2-0040" title="MazokopakisEE , PapadakisJA , PapadomanolakiMG , BatistakisAG , GiannakopoulosTG , ProtopapadakisEE , et al. Effects of 12 months treatment with L‐selenomethionine on serum anti‐TPO Levels in patients with Hashimoto's thyroiditis. Thyroid2007;17(7):609‐12. ">Mazokopakis 2007</a> was not considered eligible for our review as it was clear from the abstract that it was not a randomised controlled trial. <a href="./references#CD010223-bbs2-0003" title="NegroR , GrecoG , MangieriT , PezzarossaA , DazziD , HassanH . The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism2007;92(4):1263‐8. [PUBMED: PMID: 17284630] ">Negro 2007</a> was excluded on the basis of inclusion criteria, which stated that no pregnant women would be included; however, the second phase of this study included women after delivery and could have been included.<br/> Although the authors in <a href="./references#CD010223-bbs2-0056" title="ToulisKA , AnastasilakisAD , TzellosTG , GoulisDG , KouvelasD . Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta‐analysis. Thyroid2010;20(10):1163‐73. [PUBMED: PMID: 20883174] ">Toulis 2010</a> sought to provide evidence‐based recommendations for selenium supplementation, they failed to indicate how the quality of the evidence was rated, or how the strength of subsequent recommendations was graded. </p> <p>A recently published non‐systematic review was a valuable resource for increasing our knowledge and giving us a better understanding of the relationship between selenium and thyroid metabolism, the functions of selenium and its role in the different thyroid diseases. It did not include a systematic search of the literature, nor did it provide a critical appraisal of the studies cited as references in support of selenium supplementation for the management of Hashimoto's thyroiditis (<a href="./references#CD010223-bbs2-0023" title="DrutelA , ArchambeaudF , CaronP . Selenium and the thyroid gland: more good news for clinicians. Clincial Endocrinology2013;78(2):155‐64. [PUBMED: PMID:23046013] ">Drutel 2013</a>).<br/> Our assessments of the overall quality of the evidence and conclusions on the efficacy of selenium supplementation for Hashimoto's thyroiditis were largely in agreement with the recently updated topic summary in DynaMed, a clinical reference derived from systematic literature surveillance with explicit critical appraisal criteria (<a href="./references#CD010223-bbs2-0024" title="Hashimoto thyroiditis. DynaMed [database online] EBSCO Publishing, 2013. http://search.ebscohost.com/login.aspx?direct=true&amp;site=DynaMed&amp;id=113943 Updated August 14, 2012. Accessed January 5, 2013. ">DynaMed 2013</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010223-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/urn:x-wiley:14651858:media:CD010223:CD010223-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_t/tCD010223-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010223-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_n/nCD010223-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_n/nCD010223-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010223-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/urn:x-wiley:14651858:media:CD010223:CD010223-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_t/tCD010223-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010223-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_n/nCD010223-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_n/nCD010223-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010223-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/urn:x-wiley:14651858:media:CD010223:CD010223-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_t/tCD010223-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010223-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_n/nCD010223-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_n/nCD010223-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010223-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/urn:x-wiley:14651858:media:CD010223:CD010223-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_t/tCD010223-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Selenomethionine versus placebo, Outcome 1 Anti‐TPO antibody levels." data-id="CD010223-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_n/nCD010223-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Selenomethionine versus placebo, Outcome 1 Anti‐TPO antibody levels.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/references#CD010223-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/media/CDSR/CD010223/image_n/nCD010223-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD010223-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Research recommendations based on a gap in the evidence of the effects of selenium for Hashimoto's thyroiditis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Core elements</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Issues to consider</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Status of research for this review</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Evidence (E)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>What is the current state of the evidence?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This systematic review identified one randomised controlled trial (RCT). Incomplete evidence of efficacy and safety of selenium for Hashimoto's thyroiditis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Population (P)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis, disease stage, co‐morbidity, risk factors, gender, age, ethnic group, specific inclusion or exclusion criteria, clinical setting </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inclusion criteria: </p> <p> <ul id="CD010223-list-0013"> <li> <p>Hashimoto's thyroiditis as diagnosed by a physician and supported by serum levels of anti‐TPOAb and anti‐TgAb above the normal level of the laboratory's normal ranges. </p> </li> </ul> </p> <p>Exclusion criteria: </p> <p> <ul id="CD010223-list-0014"> <li> <p>Clinical history of hyperthyroidism.</p> </li> <li> <p>Any acute and chronic inflammatory processes.</p> </li> <li> <p>Drugs known to induce thyroid dysfunction (cytokines, lithium, amiodarone).</p> </li> <li> <p>Concomitant treatment with drugs that may affect inflammatory processes in the vascular wall. </p> </li> <li> <p>Pregnancy in the last 12 month before enrolment.</p> </li> <li> <p>No further treatment such as over‐the‐counter vitamins or trace elements or corticoid or anti‐inflammatory therapy. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention (I)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Type, frequency, dose, duration, prognostic factor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Selenium 100 µg or 200 µg supplementation (sodium selenite or selenomethionine) plus titrated LT<sub>4</sub> to maintain basal TSH within normal range for at least 3 months. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparison (C)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Type, frequency, dose, duration, prognostic factor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD010223-list-0015"> <li> <p>No control plus titrated LT<sub>4</sub> to maintain basal TSH within normal range for at least 3 months. </p> </li> </ul> <ul id="CD010223-list-0016"> <li> <p>Placebo tablets plus titrated LT<sub>4</sub> to maintain basal TSH within normal range for at least 3 months. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome (O)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Which clinical or patient‐related outcomes will the researcher need to measure, improve, influence or accomplish? Which methods of measurement should be used? </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Primary outcomes  </p> <p> <ul id="CD010223-list-0017"> <li> <p>Change from baseline in HRQoL assessed using any validated quality‐of‐life instrument at end of study. </p> </li> <li> <p>Change from baseline in symptoms such as mood, fatigue and muscle weakness assessed using any validated instrument at end of study. </p> </li> <li> <p>Proportions of participants reporting an adverse event throughout the study period.</p> </li> </ul> </p> <p>Secondary outcomes  </p> <p> <ul id="CD010223-list-0018"> <li> <p>Change from baseline in serum levels of anti‐thyroid peroxidase antibodies at end of study. </p> </li> <li> <p>Change from baseline in LT<sub>4</sub> replacement dosage at end of study. </p> </li> <li> <p>Economic costs.</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time Stamp (T)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Date of literature search or recommendation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 November 2012</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study Type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>What is the most appropriate study design to address the proposed question?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD010223-list-0019"> <li> <p>RCT (adequately powered/multi‐centred).</p> </li> <li> <p>Methods: concealment of allocation sequence.</p> </li> <li> <p>Blinding: blinding of participants, trialists and outcomes assessors.</p> </li> <li> <p>Setting: hospital/university.</p> </li> </ul> </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Research recommendations based on a gap in the evidence of the effects of selenium for Hashimoto's thyroiditis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010223-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Selenium (+LT4) compared to placebo (+LT4) for participants with Hashimoto's thyroiditis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Selenium (+LT<sub>4</sub>) compared with placebo (+LT<sub>4</sub>) for participants with Hashimoto's thyroiditis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with Hashimoto's thyroiditis.<br/> <b>Settings:</b> hospital outpatient department.<br/> <b>Intervention:</b> selenium (+ levothyroxine)<sup>a.</sup> <br/> <b>Comparison:</b> placebo (+ levothyroxine). </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo (+ levothyroxine)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Selenium <br/> (+ levothyroxine)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change from baseline in health‐related quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported in any study</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change from baseline in assessment of symptoms such as mood, fatigue and muscle weakness</b> <br/> Short‐Form Health Survey<br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>167 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>778 per 1000</b> <br/> (268 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 4.67</b> <br/> (1.61 to 13.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>low</b><sup>b,c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of participants reporting an adverse event</b> <br/> Follow‐up: mean 5 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.71</b> <br/> (0.29 to 25.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>258<br/> (3 studies<sup>e</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants in placebo group counted twice (same participants in both comparisons)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change from baseline in serum levels of anti‐thyroid peroxidase antibodies</b> <br/> Decrease from 1508 to 25 IU/L<br/> Follow‐up: mean 4.5 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>252<br/> (4 studies<sup>e</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data could not be pooled because of substantial clinical heterogeneity of participants, interventions and controls </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change from baseline in LT<sub>4</sub> replacement dosage at end of study</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported in any study</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Economic costs</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported in any study</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence:<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD010223-bbs2-0001" title="KaranikasG , SchuetzM , KonturS , DuanH , KommataS , SchoenR , et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid2008;18(1):7‐12. [PUBMED: PMID: 18302514] ">Karanikas 2008</a> and <a href="./references#CD010223-bbs2-0004" title="TurkerO , KumanliogluK , KarapolatI , DoganI . Selenium treatment in autoimmune thyroiditis: 9‐month follow‐up with variable doses. Journal of Endocrinology2006;190(1):151‐6. [PUBMED: PMID: 16837619] ">Turker 2006</a> included levothyroxine in both treatment arms. <a href="./references#CD010223-bbs2-0002" title="KrysiakR , OkopienB . The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism2011;96(7):2206‐15. [PUBMED: PMID: 21508145] ">Krysiak 2011</a> included levothyroxine in one arm combined with selenium.<br/> <sup>b</sup>Randomisation was probably based on prognostic factors, and no mention was made of stratified randomisation.<br/> <sup>c</sup>Wide confidence interval.<br/> <sup>d</sup>RR 4.67.<br/> <sup>e</sup>One study provided two comparisons. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Selenium (+LT4) compared to placebo (+LT4) for participants with Hashimoto's thyroiditis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010223-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Explanation</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Auto‐antigen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usually a normal protein or complex of proteins (sometimes deoxyribonucleic acid (DNA) or ribonucleic acid (RNA)) that is recognised by the immune system of patients suffering from a specific auto‐immune disease. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Antibody</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Produced by immune cells, B cells, to identify and neutralise foreign objects such as bacteria and viruses. The antibody recognises a unique part of the foreign target, called an <i>antigen</i>; this might also be an auto‐antigen. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Atherosclerosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A condition in which an artery wall thickens as a result of the accumulation of fatty materials such as cholesterol. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Biosynthesis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An enzyme‐catalysed process in cells of living organisms by which substrates are converted to more complex products. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cytokines</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small protein molecules, secreted by several types of cells to stimulate other cells.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CD4+ T‐helper cells</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A subgroup of T‐cell lymphocytes, a type of white blood cell that plays an important role in the immune system, particularly the adaptive immune system. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CD8+ cytotoxic T cells</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A subgroup of T‐cell lymphocytes that induce the death of cells infected with viruses (and other pathogens) or otherwise damaged or dysfunctional. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dyslipidaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High cholesterol or fat levels in the blood.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Goitre</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A swelling in the thyroid gland.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GPx4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Phospholipid hydroperoxide glutathione peroxidase, a selenoprotein enzyme.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GPx</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Glutathione peroxidase, a selenoprotein enzyme that has an antioxidant function.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Homeostasis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A state of balanced levels of the molecule in the human body.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hyperglycaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High glucose levels in the blood.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IFN‐γ</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interferon‐gamma; a cytokine or type II interferon that is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumour control. Aberrant IFN‐γ expression is associated with a number of auto‐inflammatory and auto‐immune diseases. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LDL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low‐density lipoproteins or 'bad' cholesterol.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Macrophage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A type of immune cell that differentiates from monocytes in tissue and phagocytises (engulfs) foreign materials. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pancreatitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inflammation of the pancreas.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rheumatoid arthritis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A chronic, systemic inflammatory disorder that may affect many tissues and organs but principally attacks flexible (synovial) joints. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selenoprotein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selenium incorporated into proteins.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Stroke</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A condition of impaired blood supply to the brain resulting in rapid loss of brain function(s). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thyrocyte</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thyroid gland epithelial cells.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitiligo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An auto‐immune disorder that affects the skin, causing loss of pigment.</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010223-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of study populations</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Characteristic</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>[N] Screened/eligible</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>[N] Randomised</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>[N] Safety</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>[N] ITT</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>[N] Finishing study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>[%] Randomised finishing study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Follow‐up<sup>a</sup> </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Karanikas 2008</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: LT<sub>4</sub> + 200 μg sodium selenite </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: LT<sub>4</sub> + placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>total:</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="5" valign="top"> <p><b>Krysiak 2011</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I1: Levothyroxine sodium</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I2: Selenomethionine 200 μg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I3: Levothyroxine sodium<br/> + selenomethionine 200 μg </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C1: Placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>total:</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>165</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>165</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Negro 2007</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: 200 μg selenomethionine</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2227</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>from 12 weeks' gestation to12 months' post partum</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: Placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>total:</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>169</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Turker 2006</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: LT<sub>4</sub> + 200 μg + L‐selenomethionine </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: LT<sub>4</sub> + placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>total:</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b><i>Total</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All interventions</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>279</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All controls</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>184</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All interventions and controls</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>463</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>a</sup>Duration of intervention and/or follow‐up under randomised conditions until end of study. </p> <p>‐ = not reported.</p> <p>ITT: intention‐to‐treat; N/A: not applicable.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of study populations</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/full#CD010223-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010223-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Selenomethionine versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Anti‐TPO antibody levels <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 1700 IU/mL levels at baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐917.0 [‐1029.16, ‐804.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 600 IU/mL at baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐345.0 [‐358.79, ‐331.21]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Selenomethionine versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010223.pub2/references#CD010223-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010223.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010223-note-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010223-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010223-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD010223-note-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD010223-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD010223-note-0003">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD010223-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD010223-note-0007">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010223-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010223\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010223\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010223\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010223\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010223\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=p32VIvbS&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010223.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010223.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010223.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010223.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010223.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725904679"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010223.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725904682"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010223.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e86a24c2c9371',t:'MTc0MDcyNTkwNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 